"ID","FLDNAME","TBLNAME","CRFNAME","QUESTION","TEXT","STATUS","DEPRULE","TYPE","LENGTH","DECIML","RANGEVAL","RANGESQL","RANGEPRL","UNITS","CODE","NOTES","OBJID","COLID","RANGEJSCPT","NAVJSCPT","FTYPE","TAB","DE","MC","VISIBLE","LOGVISIBLE","MTBLNAME","SUBTBLNAME","POPJSCPT","GRID","DEF","update_stamp"
"","RID","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Participant roster ID. NOTE: 9999999 denotes pooled sample.","-4","-4","-4","-4","","-4","-4","-4","-4","-4","The 4 digit roster ID (RID) should be used to merge data","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","Plate.Bar.Code","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Unique identifier for every plate generated by the Biocrates MetIDQ software","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = Separate bar codes are generated for the UPLC and FIA plates (for this study there are 11 UPLC Plate Bar Codes and 11 FIA Plate Bar Codes); MOLECULEWEIGHT = NA; MOLECULARFORMULA = ; KEGG = ; MOLECULE = ; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = ; ISOMERIC = ; INCHI = ; MESH = ; LMID = ","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","Sample.Bar.Code","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Unique identifier for every sample registered in the Biocrates MetIDQ software","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = This bar code number is the same for both UPLC and FIA samples; MOLECULEWEIGHT = NA; MOLECULARFORMULA = ; KEGG = ; MOLECULE = ; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = ; ISOMERIC = ; INCHI = ; MESH = ; LMID = ","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","Sample.Identification","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Unique identifier for every sample entered in the Duke Proteomics Sample Sumbission System.","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = NA; MOLECULARFORMULA = ; KEGG = ; MOLECULE = ; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = ; ISOMERIC = ; INCHI = ; MESH = ; LMID = ","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","Species","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Species of sample origin","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = NA; MOLECULARFORMULA = ; KEGG = ; MOLECULE = ; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = ; ISOMERIC = ; INCHI = ; MESH = ; LMID = ","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","Material","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","For this study the samples are serum","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = QC samples are plasma; MOLECULEWEIGHT = NA; MOLECULARFORMULA = ; KEGG = ; MOLECULE = ; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = ; ISOMERIC = ; INCHI = ; MESH = ; LMID = ","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","Well.Position","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Well number in the 96-well plate from which the sample was injected","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = NA; MOLECULARFORMULA = ; KEGG = ; MOLECULE = ; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = ; ISOMERIC = ; INCHI = ; MESH = ; LMID = ","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","Sample.Volume","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","The volume of sample injected in microliters","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = NA; MOLECULARFORMULA = ; KEGG = ; MOLECULE = ; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = ; ISOMERIC = ; INCHI = ; MESH = ; LMID = ","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","C0","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Carnitine","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 161.1989; MOLECULARFORMULA = C7H15NO3; KEGG = ; MOLECULE = D-Carnitine; CAS = 541-14-0; INCHIKEY = PHIQHXFUZVPYII-LURJTMIESA-N; HMDB = ; CHEBI = 11060               ; IUPAC = (3S)-3-hydroxy-4-(trimethylazaniumyl)butanoate; ISOMERIC = C[N+](C)(C)C[C@H](CC(=O)[O-])O; INCHI = InChI=1S/C7H15NO3/c1-8(2,3)5-6(9)4-7(10)11/h6,9H,4-5H2,1-3H3/t6-/m0/s1; MESH = Carnitine; LMID = ","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","C10","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Decanoylcarnitine","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 315.44822; MOLECULARFORMULA = C17H33NO4; KEGG = ; MOLECULE = Decanoylcarnitine; CAS = 1492-27-9; INCHIKEY = LZOSYCMHQXPBFU-UHFFFAOYSA-N; HMDB = HMDB00651           ; CHEBI = ; IUPAC = 3-decanoyloxy-4-(trimethylazaniumyl)butanoate; ISOMERIC = CCCCCCCCCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C; INCHI = InChI=1S/C17H33NO4/c1-5-6-7-8-9-10-11-12-17(21)22-15(13-16(19)20)14-18(2,3)4/h15H,5-14H2,1-4H3; MESH = Decanoylcarnitine; LMID = ","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","C10.1","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Decenoylcarnitine","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 313.4349; MOLECULARFORMULA = C17H31NO4; KEGG = C02301; MOLECULE = O-Acylcarnitine; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = 17387               ; IUPAC = 3-Acyloxy-4-(trimethylazaniumyl)butanoate; ISOMERIC = ; INCHI = ; MESH = Acylcarnitine; LMID = LMFA0707","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","C10.2","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Decadienylcarnitine","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 311.4191; MOLECULARFORMULA = C17H29NO4; KEGG = C02301; MOLECULE = O-Acylcarnitine; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = 17387               ; IUPAC = 3-Acyloxy-4-(trimethylazaniumyl)butanoate; ISOMERIC = ; INCHI = ; MESH = Acylcarnitine; LMID = LMFA0707","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","C12","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Dodecanoylcarnitine","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 343.50138; MOLECULARFORMULA = C19H37NO4; KEGG = ; MOLECULE = Dodecanoyl-L-carnitine; CAS = 25518-54-1; INCHIKEY = FUJLYHJROOYKRA-QGZVFWFLSA-N; HMDB = HMDB02250           ; CHEBI = ; IUPAC = (3R)-3-dodecanoyloxy-4-(trimethylazaniumyl)butanoate; ISOMERIC = CCCCCCCCCCCC(=O)O[C@H](CC(=O)[O-])C[N+](C)(C)C; INCHI = InChI=1S/C19H37NO4/c1-5-6-7-8-9-10-11-12-13-14-19(23)24-17(15-18(21)22)16-20(2,3)4/h17H,5-16H2,1-4H3/t17-/m1/s1; MESH = Lauroylcarnitine; LMID = ","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","C12.DC","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Dodecanedioylcarnitine","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 373.4865; MOLECULARFORMULA = C19H35NO6; KEGG = C02301; MOLECULE = O-Acylcarnitine; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = 17387               ; IUPAC = 3-Acyloxy-4-(trimethylazaniumyl)butanoate; ISOMERIC = ; INCHI = ; MESH = Acylcarnitine; LMID = LMFA0707","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","C12.1","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Dodecenoylcarnitine","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 341.4885; MOLECULARFORMULA = C19H35NO4; KEGG = ; MOLECULE = Dodecenoylcarnitine; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = 17387               ; IUPAC = 3-Acyloxy-4-(trimethylazaniumyl)butanoate; ISOMERIC = ; INCHI = ; MESH = Acylcarnitine; LMID = LMFA0707","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","C14","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Tetradecanoylcarnitine","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 371.5579; MOLECULARFORMULA = C21H41NO4; KEGG = ; MOLECULE = Myristyl-L-carnitine; CAS = 25597-07-3; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = (3R)-3-tetradecanoyloxy-4-(trimethylazaniumyl)butanoate; ISOMERIC = CCCCCCCCCCCCCC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C; INCHI = ; MESH = Myristoylcarnitine; LMID = ","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","C14.1","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Tetradecenoylcarnitine","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 369.5421; MOLECULARFORMULA = C21H39NO4; KEGG = ; MOLECULE = C14:1; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = ; ISOMERIC = ; INCHI = ; MESH = ; LMID = ","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","C14.1.OH","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Hydroxytetradecenoylcarnitine","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 358.5411; MOLECULARFORMULA = C21H39NO5; KEGG = ; MOLECULE = C14:1-OH; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = ; ISOMERIC = ; INCHI = ; MESH = ; LMID = ","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","C14.2","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Tetradecadienylcarnitine","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 367.5263; MOLECULARFORMULA = C21H37NO4; KEGG = ; MOLECULE = C14:2; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = ; ISOMERIC = ; INCHI = ; MESH = ; LMID = ","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","C14.2.OH","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Hydroxytetradecadienylcarnitine","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 383.5253; MOLECULARFORMULA = C21H37NO5; KEGG = ; MOLECULE = C14:2-OH; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = ; ISOMERIC = ; INCHI = ; MESH = ; LMID = ","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","C16","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Hexadecanoylcarnitine","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 399.6077; MOLECULARFORMULA = C23H45NO4; KEGG = ; MOLECULE = D-Palmitoylcarnitine; CAS = 2364-66-1; INCHIKEY = XOMRRQXKHMYMOC-NRFANRHFSA-N; HMDB = ; CHEBI = ; IUPAC = (3S)-3-hexadecanoyloxy-4-(trimethylazaniumyl)butanoate; ISOMERIC = CCCCCCCCCCCCCCCC(=O)O[C@@H](CC(=O)[O-])C[N+](C)(C)C; INCHI = InChI=1S/C23H45NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-23(27)28-21(19-22(25)26)20-24(2,3)4/h21H,5-20H2,1-4H3/t21-/m0/s1; MESH = Palmitoylcarnitine; LMID = ","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","C16.OH","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Hydroxyhexadecanoylcarnitine","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 415.6105; MOLECULARFORMULA = C23H45NO5; KEGG = C02301; MOLECULE = O-Acylcarnitine; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = 17387               ; IUPAC = 3-Acyloxy-4-(trimethylazaniumyl)butanoate; ISOMERIC = ; INCHI = ; MESH = Acylcarnitine; LMID = LMFA0707","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","C16.1","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Hexadecenoylcarnitine","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 397.5957; MOLECULARFORMULA = C23H43NO4; KEGG = ; MOLECULE = Palmitoleylcarnitine; CAS = ; INCHIKEY = ; HMDB = HMDB06317           ; CHEBI = ; IUPAC = (2E)-Hexadecenoyloxy-4-(trimethylazaniumyl)butanoate; ISOMERIC = CCCCCCCCCCCCCC=CC(=O)OC(CC([O-])=O)C[N+](C)(C)C; INCHI = ; MESH = Acylcarnitine; LMID = ","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","C16.1.OH","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Hydroxyhexadecenoylcarnitine","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 413.5947; MOLECULARFORMULA = C23H43NO5; KEGG = C02301; MOLECULE = O-Acylcarnitine; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = 17387               ; IUPAC = 3-Acyloxy-4-(trimethylazaniumyl)butanoate; ISOMERIC = ; INCHI = ; MESH = Acylcarnitine; LMID = LMFA0707","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","C16.2","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Hexadecadienylcarnitine","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 395.5799; MOLECULARFORMULA = C23H41NO4; KEGG = ; MOLECULE = C16:2; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = ; ISOMERIC = ; INCHI = ; MESH = ; LMID = ","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","C16.2.OH","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Hydroxyhexadecadienylcarnitine","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 411.5789; MOLECULARFORMULA = C23H41NO5; KEGG = ; MOLECULE = C16:2-OH; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = ; ISOMERIC = ; INCHI = ; MESH = ; LMID = ","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","C18","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Octadecanoylcarnitine","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 427.66086; MOLECULARFORMULA = C25H49NO4; KEGG = ; MOLECULE = Stearoylcarnitine; CAS = 1976-27-8; INCHIKEY = FNPHNLNTJNMAEE-UHFFFAOYSA-N; HMDB = HMDB00848           ; CHEBI = ; IUPAC = 3-octadecanoyloxy-4-(trimethylazaniumyl)butanoate; ISOMERIC = CCCCCCCCCCCCCCCCCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C; INCHI = InChI=1S/C25H49NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-25(29)30-23(21-24(27)28)22-26(2,3)4/h23H,5-22H2,1-4H3; MESH = Acylcarnitine; LMID = ","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","C18.1","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Octadecenoylcarnitine","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 425.645; MOLECULARFORMULA = C25H47NO4; KEGG = ; MOLECULE = Elaidic carnitine; CAS = ; INCHIKEY = ; HMDB = HMDB06464           ; CHEBI = ; IUPAC = 3-[(E)-octadec-9-enoyl]oxy-4-(trimethylazaniumyl)butanoate; ISOMERIC = CCCCCCCCC=CCCCCCCCC(=O)OC(CC([O-])=O)C[N+](C)(C)C; INCHI = ; MESH = Oleoylcarnitine; LMID = ","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","C18.1.OH","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Hydroxyoctadecenoylcarnitine","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 441.6483; MOLECULARFORMULA = C25H47NO5; KEGG = ; MOLECULE = Hydroxyoctadecenoylcarnitine; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = 17387               ; IUPAC = 3-Acyloxy-4-(trimethylazaniumyl)butanoate; ISOMERIC = ; INCHI = ; MESH = Acylcarnitine; LMID = LMFA0707","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","C18.2","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Octadecadienylcarnitine","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 423.6291; MOLECULARFORMULA = C25H45NO4; KEGG = ; MOLECULE = Linoelaidylcarnitine; CAS = ; INCHIKEY = ; HMDB = HMDB06461           ; CHEBI = ; IUPAC = 3-[(9E,12E)-octadeca-9,12-dienoyl]oxy-4-(trimethylazaniumyl)butanoate; ISOMERIC = CCCCCC=CCC=CCCCCCCCC(=O)OC(CC([O-])=O)C[N+](C)(C)C; INCHI = ; MESH = Linoleoylcarnitine; LMID = ","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","C2","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Acetylcarnitine","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 203.23558; MOLECULARFORMULA = C9H17NO4; KEGG = C02571; MOLECULE = Acetyl-L-carnitine; CAS = 14992-62-2; INCHIKEY = RDHQFKQIGNGIED-MRVPVSSYSA-N; HMDB = ; CHEBI = 15960               ; IUPAC = (3R)-3-acetyloxy-4-(trimethylazaniumyl)butanoate; ISOMERIC = [O-]C(=O)C[C@@H](OC(=O)C)C[N+](C)(C)C; INCHI = InChI=1S/C9H17NO4/c1-7(11)14-8(5-9(12)13)6-10(2,3)4/h8H,5-6H2,1-4H3/t8-/m1/s1; MESH = Acetylcarnitine; LMID = ","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","C3","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Propionylcarnitine","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 217.26216; MOLECULARFORMULA = C10H19NO4; KEGG = ; MOLECULE = Propionyl-L-carnitine; CAS = 113817-31-5; INCHIKEY = UFAHZIUFPNSHSL-MRVPVSSYSA-N; HMDB = ; CHEBI = ; IUPAC = (3R)-3-propanoyloxy-4-(trimethylazaniumyl)butanoate; ISOMERIC = CCC(=O)O[C@H](CC(=O)[O-])C[N+](C)(C)C; INCHI = InChI=1S/C10H19NO4/c1-5-10(14)15-8(6-9(12)13)7-11(2,3)4/h8H,5-7H2,1-4H3/t8-/m1/s1; MESH = Propionylcarnitine; LMID = ","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","C3.DC..C4.OH.","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Malonylcarnitine (Hydroxybutyrylcarnitine)","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 247.2453; MOLECULARFORMULA = C10H17NO6; KEGG = ; MOLECULE = Malonyl-L-carnitine; CAS = ; INCHIKEY = ; HMDB = HMDB02095           ; CHEBI = ; IUPAC = (3R)-3-(3-hydroxy-3-oxopropanoyl)oxy-4-(trimethylazaniumyl)butanoate; ISOMERIC = C[N+](C)(C)C[C@H](CC([O-])=O)OC(=O)CC(O)=O; INCHI = ? InChI=1S/C10H17NO6/c1-11(2,3)6-7(4-8(12)13)17-10(16)5-9(14)15/h7H,4-6H2,1-3H3,(H-,12,13,14,15)/t7-/m1/s1; MESH = Acylcarnitine; LMID = ","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","C3.OH","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Hydroxypropionylcarnitine","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 233.2621; MOLECULARFORMULA = C10H19NO5; KEGG = ; MOLECULE = C3-OH; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = ; ISOMERIC = ; INCHI = ; MESH = ; LMID = ","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","C3.1","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Propenylcarnitine","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 215.2473; MOLECULARFORMULA = C10H17NO4; KEGG = ; MOLECULE = Propenylcarnitine; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = 17387               ; IUPAC = 3-Acyloxy-4-(trimethylazaniumyl)butanoate; ISOMERIC = ; INCHI = ; MESH = Acylcarnitine; LMID = LMFA0707","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","C4","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Butyrylcarnitine (Isobutyrylcarnitine)","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 231.28874; MOLECULARFORMULA = C11H21NO4; KEGG = ; MOLECULE = Isobutyrylcarnitine; CAS = ; INCHIKEY = LRCNOZRCYBNMEP-UHFFFAOYSA-N; HMDB = ; CHEBI = ; IUPAC = 3-(2-methylpropanoyloxy)-4-(trimethylazaniumyl)butanoate; ISOMERIC = CC(C)C(=O)OC(CC(=O)[O-])C[N+](C)(C)C; INCHI = InChI=1S/C11H21NO4/c1-8(2)11(15)16-9(6-10(13)14)7-12(3,4)5/h8-9H,6-7H2,1-5H3; MESH = Isobutyrylcarnitine; LMID = ","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","C4.1","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Butenylcarnitine","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 229.2741; MOLECULARFORMULA = C11H19NO4; KEGG = C02301; MOLECULE = Butenyl-L-carnitine; CAS = ; INCHIKEY = ; HMDB = HMDB13126           ; CHEBI = 17387               ; IUPAC = (3R)-butenoyloxy-4-(trimethylazaniumyl)butanoate; ISOMERIC = ; INCHI = InChI=1S/C11H19NO4/c1-5-6-11(15)16-9(7-10(13)14)8-12(2,3)4/h5-6,9H,7-8H2,1-4H3/b6-5+/t9-/m0/s1; MESH = Acylcarnitine; LMID = ","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","C6..C4.1.DC.","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Hexanoylcarnitine (Fumarylcarnitine)","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 259.3435; MOLECULARFORMULA = C13H25NO4; KEGG = ; MOLECULE = C6 (C4:1-DC); CAS = ; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = ; ISOMERIC = ; INCHI = ; MESH = ; LMID = ","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","C5","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Isovalerylcarnitine (Methylbutylcarnitine, Valerylcarnitine)","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 245.31532; MOLECULARFORMULA = C12H23NO4; KEGG = ; MOLECULE = Valerylcarnitine; CAS = ; INCHIKEY = VSNFQQXVMPSASB-UHFFFAOYSA-N; HMDB = ; CHEBI = ; IUPAC = 3-pentanoyloxy-4-(trimethylazaniumyl)butanoate; ISOMERIC = CCCCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C; INCHI = InChI=1S/C12H23NO4/c1-5-6-7-12(16)17-10(8-11(14)15)9-13(2,3)4/h10H,5-9H2,1-4H3; MESH = Acylcarnitine; LMID = ","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","C5.M.DC","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Methylglutarylcarnitine","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 289.32482; MOLECULARFORMULA = C13H23NO6; KEGG = ; MOLECULE = Methylglutarylcarnitine; CAS = 102673-95-0; INCHIKEY = HFCPFJNSBPQJDP-UHFFFAOYSA-N; HMDB = HMDB00552           ; CHEBI = ; IUPAC = 5-[4-hydroxy-4-oxo-1-(trimethylazaniumyl)butan-2-yl]oxy-3-methyl-5-oxopentanoate; ISOMERIC = CC(CC(=O)[O-])CC(=O)OC(CC(=O)O)C[N+](C)(C)C; INCHI = InChI=1S/C13H23NO6/c1-9(5-11(15)16)6-13(19)20-10(7-12(17)18)8-14(2,3)4/h9-10H,5-8H2,1-4H3,(H-,15,16,17,18); MESH = 3-methylglutarylcarnitine; LMID = ","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","C5.OH..C3.DC.M.","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Hydroxyvalerylcarnitine (Methylmalonylcarnitine)","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 261.3157; MOLECULARFORMULA = C12H23NO5; KEGG = ; MOLECULE = Hydroxyvalerylcarnitine (Methylmalonylcarnitine); CAS = ; INCHIKEY = ; HMDB = ; CHEBI = 17387               ; IUPAC = 3-Acyloxy-4-(trimethylazaniumyl)butanoate; ISOMERIC = ; INCHI = ; MESH = Acylcarnitine; LMID = LMFA0707","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","C5.1","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Tiglylcarnitine","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 243.29944; MOLECULARFORMULA = C12H21NO4; KEGG = ; MOLECULE = Tiglylcarnitine; CAS = 64191-86-2; INCHIKEY = WURBQCVBQNMUQT-RMKNXTFCSA-N; HMDB = HMDB02366           ; CHEBI = ; IUPAC = 3-[(E)-2-methylbut-2-enoyl]oxy-4-(trimethylazaniumyl)butanoate; ISOMERIC = C/C=C(\C)/C(=O)OC(CC(=O)[O-])C[N+](C)(C)C; INCHI = InChI=1S/C12H21NO4/c1-6-9(2)12(16)17-10(7-11(14)15)8-13(3,4)5/h6,10H,7-8H2,1-5H3/b9-6+; MESH = Tiglylcarnitine; LMID = ","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","C5.1.DC","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Glutaconylcarnitine","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 273.2831; MOLECULARFORMULA = C12H19NO6; KEGG = ; MOLECULE = Glutaconylcarnitine; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = 17387               ; IUPAC = 3-Acyloxy-4-(trimethylazaniumyl)butanoate; ISOMERIC = ; INCHI = ; MESH = Acylcarnitine; LMID = LMFA0707","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","C5.DC..C6.OH.","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Glutarylcarnitine (Hydroxyhexanoylcarnitine)","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 275.2989; MOLECULARFORMULA = C12H21NO6; KEGG = ; MOLECULE = Glutarylcarnitine; CAS = ; INCHIKEY = HYVXOSFJMKWZGF-UHFFFAOYSA-N; HMDB = ; CHEBI = ; IUPAC = 5-[1-hydroxy-1-oxo-3-(trimethylazaniumyl)propan-2-yl]oxy-5-oxopentanoate; ISOMERIC = C[N+](C)(C)CC(C(=O)O)OC(=O)CCCC(=O)[O-]; INCHI = InChI=1S/C11H19NO6/c1-12(2,3)7-8(11(16)17)18-10(15)6-4-5-9(13)14/h8H,4-7H2,1-3H3,(H-,13,14,16,17); MESH = Glutarylcarnitine; LMID = ","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","C6.1","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Hexenoylcarnitine","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 257.3277; MOLECULARFORMULA = C13H23NO4; KEGG = C02301; MOLECULE = O-Acylcarnitine; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = 17387               ; IUPAC = 3-Acyloxy-4-(trimethylazaniumyl)butanoate; ISOMERIC = ; INCHI = ; MESH = Acylcarnitine; LMID = LMFA0707","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","C7.DC","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Pimelylcarnitine","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 303.3525; MOLECULARFORMULA = C14H25NO6; KEGG = C02301; MOLECULE = O-Acylcarnitine; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = 17387               ; IUPAC = 3-Acyloxy-4-(trimethylazaniumyl)butanoate; ISOMERIC = ; INCHI = ; MESH = Acylcarnitine; LMID = LMFA0707","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","C8","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Octanoylcarnitine","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 287.39506; MOLECULARFORMULA = C15H29NO4; KEGG = ; MOLECULE = Octanoylcarnitine; CAS = 3671-77-0; INCHIKEY = CXTATJFJDMJMIY-UHFFFAOYSA-N; HMDB = ; CHEBI = ; IUPAC = 3-octanoyloxy-4-(trimethylazaniumyl)butanoate; ISOMERIC = CCCCCCCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C; INCHI = InChI=1S/C15H29NO4/c1-5-6-7-8-9-10-15(19)20-13(11-14(17)18)12-16(2,3)4/h13H,5-12H2,1-4H3; MESH = Octanoylcarnitine; LMID = ","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","C9","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","Nonanoylcarnitine","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 301.4239; MOLECULARFORMULA = C16H31NO4; KEGG = ; MOLECULE = C9; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = ; ISOMERIC = ; INCHI = ; MESH = ; LMID = ","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","lysoPC.a.C14.0","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","lysoPhosphatidylcholine a C14:0","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = also possibly PC ae 14:0; MOLECULEWEIGHT = 467.5769; MOLECULARFORMULA = C22H46NO7P; KEGG = C04230; MOLECULE = C14:0 a Lysophosphatidylcholine; CAS = 13699-45-1; INCHIKEY = VXUOFDJKYGDUJI-UHFFFAOYSA-N; HMDB = ; CHEBI = ; IUPAC = (2-hydroxy-3-tetradecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)O; INCHI = InChI=1S/C22H46NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-22(25)28-19-21(24)20-30-31(26,27)29-18-17-23(2,3)4/h21,24H,5-20H2,1-4H3; MESH = Lysophosphatidylcholines; LMID = LMGP01050113","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","lysoPC.a.C16.0","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","lysoPhosphatidylcholine a C16:0","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 495.63006; MOLECULARFORMULA = C24H50NO7P; KEGG = C04230; MOLECULE = C16:0 a Lysophosphatidylcholine; CAS = 14863-27-5; INCHIKEY = ASWBNKHCZGQVJV-UHFFFAOYSA-N; HMDB = ; CHEBI = ; IUPAC = (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)O; INCHI = InChI=1S/C24H50NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-24(27)30-21-23(26)22-32-33(28,29)31-20-19-25(2,3)4/h23,26H,5-22H2,1-4H3; MESH = Lysophosphatidylcholines; LMID = LMGP01050020","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","lysoPC.a.C16.1","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","lysoPhosphatidylcholine a C16:1","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 493.61418; MOLECULARFORMULA = C24H48NO7P; KEGG = ; MOLECULE = C16:1;9Z-enoyl a L-Lysophosphatidylcholine; CAS = ; INCHIKEY = LFUDDCMNKWEORN-ZXEGGCGDSA- ; HMDB = HMDB10383           ; CHEBI = ; IUPAC = [(2R)-3-[(Z)-hexadec-9-enoyl]oxy-2-hydroxypropyl]2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)O; INCHI = InChI=1S/C24H48NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-24(27)30-21-23(26)22-32-33(28,29)31-20-19-25(2,3)4/h10-11,23,26H,5-9,12-22H2,1-4H3/b11-10-/t23-/m1/s1; MESH = Lysophosphatidylcholines; LMID = LMGP01050022","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","lysoPC.a.C17.0","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","lysoPhosphatidylcholine a C17:0","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = QA spiked Analyte; MOLECULEWEIGHT = 509.65664; MOLECULARFORMULA = C25H52NO7P; KEGG = ; MOLECULE = C17:0 a L-Lysophosphatidylcholine; CAS = ; INCHIKEY = SRRQPVVYXBTRQK-XMMPIXPASA-N; HMDB = HMDB12108           ; CHEBI = 580913              ; IUPAC = [(2R)-3-heptadecanoyloxy-2-hydroxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)O; INCHI = InChI=1S/C25H52NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-25(28)31-22-24(27)23-33-34(29,30)32-21-20-26(2,3)4/h24,27H,5-23H2,1-4H3/t24-/m1/s1; MESH = Lysophosphatidylcholines; LMID = LMGP01050024","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","lysoPC.a.C18.0","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","lysoPhosphatidylcholine a C18:0","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 523.68322; MOLECULARFORMULA = C26H54NO7P; KEGG = ; MOLECULE = C18:0 2a D-Lysophosphatidylcholine; CAS = ; INCHIKEY = IQGPMZRCLCCXAG-VWLOTQADSA-N; HMDB = ; CHEBI = ; IUPAC = [(2S)-3-hydroxy-2-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCCCC(=O)O[C@@H](CO)COP(=O)([O-])OCC[N+](C)(C)C; INCHI = InChI=1S/C26H54NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-26(29)34-25(23-28)24-33-35(30,31)32-22-21-27(2,3)4/h25,28H,5-24H2,1-4H3/t25-/m0/s1; MESH = Lysophosphatidylcholines; LMID = LMGP01050077","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","lysoPC.a.C18.1","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","lysoPhosphatidylcholine a C18:1","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 521.66734; MOLECULARFORMULA = C26H52NO7P; KEGG = ; MOLECULE = C18:1;9Z-enoyl a L-Lysophosphatidylcholine; CAS = 3542-29-8; INCHIKEY = YAMUFBLWGFFICM-PTGWMXDISA-N; HMDB = HMDB02815           ; CHEBI = ; IUPAC = [(2R)-2-hydroxy-3-[(Z)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)O; INCHI = InChI=1S/C26H52NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-26(29)32-23-25(28)24-34-35(30,31)33-22-21-27(2,3)4/h12-13,25,28H,5-11,14-24H2,1-4H3/b13-12-/t25-/m1/s1; MESH = Lysophosphatidylcholines; LMID = LMGP01050032","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","lysoPC.a.C18.2","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","lysoPhosphatidylcholine a C18:2","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 519.65146; MOLECULARFORMULA = C26H50NO7P; KEGG = ; MOLECULE = C18:1;9Z,12Z-dienoyl a L-Lysophosphatidylcholine; CAS = ; INCHIKEY = SPJFYYJXNPEZDW-FTJOPAKQSA-N; HMDB = HMDB10386           ; CHEBI = ; IUPAC = [(2R)-2-hydroxy-3-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCC/C=C\C/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)O; INCHI = InChI=1S/C26H50NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-26(29)32-23-25(28)24-34-35(30,31)33-22-21-27(2,3)4/h9-10,12-13,25,28H,5-8,11,14-24H2,1-4H3/b10-9-,13-12-/t25-/m1/s1; MESH = Lysophosphatidylcholines; LMID = LMGP01050035","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","lysoPC.a.C20.3","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","lysoPhosphatidylcholine a C20:3","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 545.6928; MOLECULARFORMULA = C28H52NO7P; KEGG = C04230; MOLECULE = (5Z,8Z,11Z) a C20:3 L-Lysophosphatidylcholine; CAS = ; INCHIKEY = YHGXYYIGHBPDMX-BUTFDPNWSA-N; HMDB = HMDB10393           ; CHEBI = ; IUPAC = [(2R)-2-hydroxy-3-[(5Z,8Z,11Z)-icosa-5,8,11,14-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCC=C/CC=C/CC=C/CCCC(=O)OC[C@@H](O)COP([O-])(=O)OCC[N+](C)(C)C; INCHI = InChI=1S/C28H52NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-28(31)34-25-27(30)26-36-37(32,33)35-24-23-29(2,3)4/h12-13,15-16,18-19,27,30H,5-11,14,17,20-26H2,1-4H3/b13-12-,16-15-,19-18-/t27-/m1/s1; MESH = Lysophosphatidylcholines; LMID = ","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","lysoPC.a.C20.4","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","lysoPhosphatidylcholine a C20:4","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 543.67286; MOLECULARFORMULA = C28H50NO7P; KEGG = C04230; MOLECULE = (5Z,8Z,11Z,14Z) a C20:4 Lysophosphatidylcholine; CAS = ; INCHIKEY = LAXQYRRMGGEGOH-SNPVRQPZSA-N; HMDB = ; CHEBI = ; IUPAC = [2-hydroxy-3-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)O; INCHI = InChI=1S/C28H50NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-28(31)34-25-27(30)26-36-37(32,33)35-24-23-29(2,3)4/h9-10,12-13,15-16,18-19,27,30H,5-8,11,14,17,20-26H2,1-4H3/b10-9-,13-12-,16-15-,19-18-; MESH = Lysophosphatidylcholines; LMID = LMGP01050049","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","lysoPC.a.C24.0","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","lysoPhosphatidylcholine a C24:0","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = also possible PC ae 24:0; MOLECULEWEIGHT = 607.8427; MOLECULARFORMULA = C32H66NO7P; KEGG = C04230; MOLECULE = C24:0 a Lysophosphatidylcholine; CAS = ; INCHIKEY = SKJMUADLQLZAGH-UHFFFAOYSA-N; HMDB = ; CHEBI = ; IUPAC = (2-hydroxy-3-tetracosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)O; INCHI = InChI=1S/C32H66NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-26-32(35)38-29-31(34)30-40-41(36,37)39-28-27-33(2,3)4/h31,34H,5-30H2,1-4H3; MESH = Lysophosphatidylcholines; LMID = LMGP01050058","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","lysoPC.a.C26.0","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","lysoPhosphatidylcholine a C26:0","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = also possible PC ae 26:0; MOLECULEWEIGHT = 635.901; MOLECULARFORMULA = C34H70NO7P; KEGG = ; MOLECULE = lysoPC a C26:0; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = ; ISOMERIC = ; INCHI = ; MESH = ; LMID = ","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","lysoPC.a.C26.1","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","lysoPhosphatidylcholine a C26:1","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = also possibly PC ae 26:1; MOLECULEWEIGHT = 633.8852; MOLECULARFORMULA = C34H68NO7P; KEGG = ; MOLECULE = lysoPC a C26:1; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = ; ISOMERIC = ; INCHI = ; MESH = ; LMID = ","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","lysoPC.a.C28.0","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","lysoPhosphatidylcholine a C28:0","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = also possibly PC ae 28:0; MOLECULEWEIGHT = 663.9546; MOLECULARFORMULA = C36H74NO7P; KEGG = ; MOLECULE = lysoPhosphatidylcholine a C28:0; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = ; ISOMERIC = ; INCHI = ; MESH = Lysophosphatidylcholines; LMID = LMGP01050000","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","lysoPC.a.C28.1","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","lysoPhosphatidylcholine a C28:1","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = also possibly PC ae 28:1; MOLECULEWEIGHT = 661.9388; MOLECULARFORMULA = C36H72NO7P; KEGG = ; MOLECULE = lysoPC a C28:1; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = ; ISOMERIC = ; INCHI = ; MESH = ; LMID = ","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.aa.C24.0","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC aa C24:0","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 621.82622; MOLECULARFORMULA = C32H64NO8P; KEGG = C00157; MOLECULE = C(11:0/13:0) aa Phosphatidylcholine; CAS = ; INCHIKEY = JSTOGINWIJTJIQ-UHFFFAOYSA-N; HMDB = ; CHEBI = ; IUPAC = (2-tridecanoyloxy-3-undecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C; INCHI = InChI=1S/C32H64NO8P/c1-6-8-10-12-14-16-17-19-21-23-25-32(35)41-30(29-40-42(36,37)39-27-26-33(3,4)5)28-38-31(34)24-22-20-18-15-13-11-9-7-2/h30H,6-29H2,1-5H3; MESH = Phosphatidylcholines; LMID = LMGP01010410","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.aa.C26.0","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC aa C26:0","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 649.87938; MOLECULARFORMULA = C34H68NO8P; KEGG = C00157; MOLECULE = C(10:0/16:0) aa Phosphatidylcholine; CAS = ; INCHIKEY = WHXGUMQFAMJVSQ-UHFFFAOYSA-N; HMDB = ; CHEBI = ; IUPAC = (2-decanoyloxy-3-hexadecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCC; INCHI = InChI=1S/C34H68NO8P/c1-6-8-10-12-14-15-16-17-18-19-21-22-24-26-33(36)40-30-32(31-42-44(38,39)41-29-28-35(3,4)5)43-34(37)27-25-23-20-13-11-9-7-2/h32H,6-31H2,1-5H3; MESH = Phosphatidylcholines; LMID = LMGP01010555","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.aa.C28.1","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC aa C28:1","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 675.91666; MOLECULARFORMULA = C36H70NO8P; KEGG = C00157; MOLECULE = C(10:0/18:1;9Z-enoyl) aa L-Phosphatidylcholine; CAS = ; INCHIKEY = LHGRLARXULFYPW-RZCWWDNZSA-N; HMDB = ; CHEBI = ; IUPAC = [(2R)-3-decanoyloxy-2-[(Z)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCC/C=C\CCCCCCCC; INCHI = InChI=1S/C36H70NO8P/c1-6-8-10-12-14-15-16-17-18-19-20-21-23-25-27-29-36(39)45-34(33-44-46(40,41)43-31-30-37(3,4)5)32-42-35(38)28-26-24-22-13-11-9-7-2/h17-18,34H,6-16,19-33H2,1-5H3/b18-17-/t34-/m1/s1; MESH = Phosphatidylcholines; LMID = LMGP01010392","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.aa.C30.0","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC aa C30:0","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 705.9857; MOLECULARFORMULA = C38H76NO8P; KEGG = ; MOLECULE = C(12:0/18:0) aa L-Phosphatidylcholine; CAS = ; INCHIKEY = BRNGDJBMPAYDPP-PSXMRANNSA-N; HMDB = ; CHEBI = ; IUPAC = [(2R)-2-dodecanoyloxy-3-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCC; INCHI = InChI=1S/C38H76NO8P/c1-6-8-10-12-14-16-17-18-19-20-21-23-24-26-28-30-37(40)44-34-36(35-46-48(42,43)45-33-32-39(3,4)5)47-38(41)31-29-27-25-22-15-13-11-9-7-2/h36H,6-35H2,1-5H3/t36-/m1/s1; MESH = Phosphatidylcholines; LMID = LMGP01010736","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.aa.C32.0","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC aa C32:0","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 734.03886; MOLECULARFORMULA = C40H80NO8P; KEGG = ; MOLECULE = C(22:0/10:0) aa L-Phosphatidylcholine; CAS = ; INCHIKEY = IOFVELCSFOVZPC-KXQOOQHDSA-N; HMDB = ; CHEBI = ; IUPAC = [(2R)-3-decanoyloxy-2-docosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C; INCHI = InChI=1S/C40H80NO8P/c1-6-8-10-12-14-15-16-17-18-19-20-21-22-23-24-25-27-29-31-33-40(43)49-38(37-48-50(44,45)47-35-34-41(3,4)5)36-46-39(42)32-30-28-26-13-11-9-7-2/h38H,6-37H2,1-5H3/t38-/m1/s1; MESH = Phosphatidylcholines; LMID = LMGP01010397","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.aa.C32.1","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC aa C32:1","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 732.02298; MOLECULARFORMULA = C40H78NO8P; KEGG = ; MOLECULE = C(14:0/18:1;9Z-enoyl)) aa L-Phosphatidylcholine; CAS = ; INCHIKEY = KIVAJCJTVPWSRJ-OQHNRNOKSA-N; HMDB = HMDB08097           ; CHEBI = ; IUPAC = [(2R)-3-[(Z)-octadec-9-enoyl]oxy-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCC/C=C\CCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C; INCHI = InChI=1S/C40H78NO8P/c1-6-8-10-12-14-16-18-19-20-21-23-24-26-28-30-32-39(42)46-36-38(37-48-50(44,45)47-35-34-41(3,4)5)49-40(43)33-31-29-27-25-22-17-15-13-11-9-7-2/h19-20,38H,6-18,21-37H2,1-5H3/b20-19-/t38-/m1/s1; MESH = Phosphatidylcholines; LMID = LMGP01010882","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.aa.C32.3","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC aa C32:3","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 727.99122; MOLECULARFORMULA = C40H74NO8P; KEGG = ; MOLECULE = C(18:3;9Z,12Z,15Z-trienoyl/14:0) aa L-Phosphatidylcholine; CAS = ; INCHIKEY = AGQKQQAJRFTOGL-XPTMXNASSA-N; HMDB = HMDB07876           ; CHEBI = ; IUPAC = [(2R)-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCC/C=C\C/C=C\C/C=C\CC; INCHI = InChI=1S/C40H74NO8P/c1-6-8-10-12-14-16-18-19-20-21-23-25-27-29-31-33-40(43)49-38(37-48-50(44,45)47-35-34-41(3,4)5)36-46-39(42)32-30-28-26-24-22-17-15-13-11-9-7-2/h8,10,14,16,19-20,38H,6-7,9,11-13,15,17-18,21-37H2,1-5H3/b10-8-,16-14-,20-19-/t38-/m1/s1; MESH = Phosphatidylcholines; LMID = LMGP01010497","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.aa.C34.1","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC aa C34:1","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 760.07614; MOLECULARFORMULA = C42H82NO8P; KEGG = ; MOLECULE = C(16:0/18:1;9E-enoyl) aa Phosphatidylcholine; CAS = ; INCHIKEY = RRVPPYNAZJRZFR-QZQOTICOSA-N; HMDB = ; CHEBI = ; IUPAC = [2-hexadecanoyloxy-3-[(E)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC/C=C/CCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C; INCHI = InChI=1S/C42H82NO8P/c1-6-8-10-12-14-16-18-20-21-23-24-26-28-30-32-34-41(44)48-38-40(39-50-52(46,47)49-37-36-43(3,4)5)51-42(45)35-33-31-29-27-25-22-19-17-15-13-11-9-7-2/h20-21,40H,6-19,22-39H2,1-5H3/b21-20+; MESH = Phosphatidylcholines; LMID = LMGP01010874","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.aa.C34.2","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC aa C34:2","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 758.06026; MOLECULARFORMULA = C42H80NO8P; KEGG = ; MOLECULE = C(16:0/18:2;9Z,12Z-dienoyl) aa Phosphatidylcholine; CAS = ; INCHIKEY = FWMYJLDHIVCJCT-AKMCNLDWSA-N; HMDB = ; CHEBI = ; IUPAC = [2-hexadecanoyloxy-3-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)COP(=O)([O-])OCC[N+](C)(C)C; INCHI = InChI=1S/C42H80NO8P/c1-6-8-10-12-14-16-18-20-21-23-24-26-28-30-32-34-41(44)48-38-40(39-50-52(46,47)49-37-36-43(3,4)5)51-42(45)35-33-31-29-27-25-22-19-17-15-13-11-9-7-2/h14,16,20-21,40H,6-13,15,17-19,22-39H2,1-5H3/b16-14-,21-20-; MESH = Phosphatidylcholines; LMID = LMGP01010933","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.aa.C34.3","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC aa C34:3","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 756.04438; MOLECULARFORMULA = C42H78NO8P; KEGG = ; MOLECULE = C(18:2;9Z,12Z-dienoyl/16:1;9Z-enoyl) aa Phosphatidylcholine; CAS = ; INCHIKEY = QJWDAOSZZYVBJZ-BOAYSYCPSA-N; HMDB = ; CHEBI = ; IUPAC = [3-[(Z)-hexadec-9-enoyl]oxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCC/C=C\CCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC; INCHI = InChI=1S/C42H78NO8P/c1-6-8-10-12-14-16-18-20-21-23-25-27-29-31-33-35-42(45)51-40(39-50-52(46,47)49-37-36-43(3,4)5)38-48-41(44)34-32-30-28-26-24-22-19-17-15-13-11-9-7-2/h14,16-17,19-21,40H,6-13,15,18,22-39H2,1-5H3/b16-14-,19-17-,21-20-; MESH = Phosphatidylcholines; LMID = LMGP01010691","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.aa.C34.4","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC aa C34:4","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 754.0285; MOLECULARFORMULA = C42H76NO8P; KEGG = ; MOLECULE = C(16:0/18:4;9Z,11E,13E,15Z-tetraenoyl) aa L-Phosphatidylcholine; CAS = ; INCHIKEY = LLSIEEJQAIIPGC-LPWSJWGQSA-N; HMDB = ; CHEBI = ; IUPAC = [(2R)-2-hexadecanoyloxy-3-[(9Z,11E,13E,15Z)-octadeca-9,11,13,15-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCC/C=C\C=C\C=C\C=C/CC)COP(=O)([O-])OCC[N+](C)(C)C; INCHI = InChI=1S/C42H76NO8P/c1-6-8-10-12-14-16-18-20-21-23-24-26-28-30-32-34-41(44)48-38-40(39-50-52(46,47)49-37-36-43(3,4)5)51-42(45)35-33-31-29-27-25-22-19-17-15-13-11-9-7-2/h8,10,12,14,16,18,20-21,40H,6-7,9,11,13,15,17,19,22-39H2,1-5H3/b10-8-,14-12+,18-16+,21-20-/t40-/m1/s1; MESH = Phosphatidylcholines; LMID = LMGP01010963","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.aa.C36.0","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC aa C36:0","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 790.14518; MOLECULARFORMULA = C44H88NO8P; KEGG = ; MOLECULE = C(26:0/10:0) aa Phosphatidylcholine; CAS = ; INCHIKEY = RHUGVIAYSFAIRX-UHFFFAOYSA-N; HMDB = ; CHEBI = ; IUPAC = (3-decanoyloxy-2-hexacosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C; INCHI = InChI=1S/C44H88NO8P/c1-6-8-10-12-14-15-16-17-18-19-20-21-22-23-24-25-26-27-28-29-31-33-35-37-44(47)53-42(41-52-54(48,49)51-39-38-45(3,4)5)40-50-43(46)36-34-32-30-13-11-9-7-2/h42H,6-41H2,1-5H3; MESH = Phosphatidylcholines; LMID = LMGP01010402","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.aa.C36.1","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC aa C36:1","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 788.1293; MOLECULARFORMULA = C44H86NO8P; KEGG = ; MOLECULE = C(18:1;9Z-enoyl/18:0) aa Phosphatidylcholine; CAS = ; INCHIKEY = ATHVAWFAEPLPPQ-LNVKXUELSA-N; HMDB = ; CHEBI = ; IUPAC = [3-octadecanoyloxy-2-[(Z)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCC/C=C\CCCCCCCC; INCHI = InChI=1S/C44H86NO8P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-43(46)50-40-42(41-52-54(48,49)51-39-38-45(3,4)5)53-44(47)37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h21,23,42H,6-20,22,24-41H2,1-5H3/b23-21-; MESH = Phosphatidylcholines; LMID = LMGP01010763","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.aa.C36.2","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC aa C36:2","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 786.11342; MOLECULARFORMULA = C44H84NO8P; KEGG = ; MOLECULE = C(18:0/18:2;9Z,12Z-dienoyl) aa L-Phosphatidylcholine; CAS = ; INCHIKEY = DZPKSVTWWIZUMS-FPUNCOTOSA-N; HMDB = HMDB08135           ; CHEBI = ; IUPAC = [(2R)-3-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-2-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)COP(=O)([O-])OCC[N+](C)(C)C; INCHI = InChI=1S/C44H84NO8P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-43(46)50-40-42(41-52-54(48,49)51-39-38-45(3,4)5)53-44(47)37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h14,16,20,22,42H,6-13,15,17-19,21,23-41H2,1-5H3/b16-14-,22-20-/t42-/m1/s1; MESH = Phosphatidylcholines; LMID = LMGP01010935","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.aa.C36.3","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC aa C36:3","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 784.09754; MOLECULARFORMULA = C44H82NO8P; KEGG = ; MOLECULE = C(18:3;6Z,9Z,12Z-trienoyl/18:0) aa Phosphatidylcholine; CAS = ; INCHIKEY = KJVJKBRMUDGTKA-YEHNNDABSA-N; HMDB = HMDB08040           ; CHEBI = ; IUPAC = [3-octadecanoyloxy-2-[(6Z,9Z,12Z)-octadeca-6,9,12-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCC/C=C\C/C=C\C/C=C\CCCCC; INCHI = InChI=1S/C44H82NO8P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-43(46)50-40-42(41-52-54(48,49)51-39-38-45(3,4)5)53-44(47)37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h15,17,21,23,27,29,42H,6-14,16,18-20,22,24-26,28,30-41H2,1-5H3/b17-15-,23-21-,29-27-; MESH = Phosphatidylcholines; LMID = LMGP01010770","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.aa.C36.4","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC aa C36:4","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 782.08166; MOLECULARFORMULA = C44H80NO8P; KEGG = ; MOLECULE = C(18:2;9Z,12Z-dienoyl/18:2;9Z,12Z-dienoyl) aa D-Phosphatidylcholine; CAS = ; INCHIKEY = FVXDQWZBHIXIEJ-KWFLKNEZSA-N; HMDB = ; CHEBI = ; IUPAC = [(2S)-2,3-bis[[(9Z,12Z)-octadeca-9,12-dienoyl]oxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCC/C=C\C/C=C\CCCCCCCC(=O)OC[C@@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC; INCHI = InChI=1S/C44H80NO8P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-43(46)50-40-42(41-52-54(48,49)51-39-38-45(3,4)5)53-44(47)37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h14-17,20-23,42H,6-13,18-19,24-41H2,1-5H3/b16-14-,17-15-,22-20-,23-21-/t42-/m0/s1; MESH = Phosphatidylcholines; LMID = LMGP01010938","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.aa.C36.5","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC aa C36:5","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 780.06578; MOLECULARFORMULA = C44H78NO8P; KEGG = ; MOLECULE = C(18:1;11Z-enoyl/18:4;2E,4E,6E,11Z-tetraenoyl) aa Phosphatidylcholine; CAS = ; INCHIKEY = ARGATSLPVXBCMK-LKOVEYLASA-N; HMDB = ; CHEBI = ; IUPAC = [3-[(2E,4E,6E,11Z)-octadeca-2,4,6,11-tetraenoyl]oxy-2-[(Z)-octadec-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCC/C=C\CCCCCCCCCC(=O)OC(COC(=O)/C=C/C=C/C=C/CCC/C=C\CCCCCC)COP(=O)([O-])OCC[N+](C)(C)C; INCHI = InChI=1S/C44H78NO8P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-43(46)50-40-42(41-52-54(48,49)51-39-38-45(3,4)5)53-44(47)37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h16-19,26,28,30,32,34,36,42H,6-15,20-25,27,29,31,33,35,37-41H2,1-5H3/b18-16-,19-17-,28-26+,32-30+,36-34+; MESH = Phosphatidylcholines; LMID = LMGP01010958","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.aa.C36.6","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC aa C36:6","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 778.0499; MOLECULARFORMULA = C44H76NO8P; KEGG = ; MOLECULE = C(18:3;9E,11E,13E-trienoyl/18:3;9E,11E,13E-trienoyl) aa Phosphatidylcholine; CAS = ; INCHIKEY = GQJQPGHLMIZLHW-QXHXEXEXSA-N; HMDB = ; CHEBI = ; IUPAC = 2,3-bis[[(9E,11E,13E)-octadeca-9,11,13-trienoyl]oxy]propyl 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCC/C=C/C=C/C=C/CCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCC/C=C/C=C/C=C/CCCC; INCHI = InChI=1S/C44H76NO8P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-43(46)50-40-42(41-52-54(48,49)51-39-38-45(3,4)5)53-44(47)37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h12-23,42H,6-11,24-41H2,1-5H3/b14-12+,15-13+,18-16+,19-17+,22-20+,23-21+; MESH = Phosphatidylcholines; LMID = LMGP01010953","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.aa.C38.0","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC aa C38:0","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 818.19834; MOLECULARFORMULA = C46H92NO8P; KEGG = ; MOLECULE = C(12:0/26:0) aa Phosphatidylcholine; CAS = ; INCHIKEY = OJWKXYOLMFAVMM-UHFFFAOYSA-N; HMDB = ; CHEBI = ; IUPAC = (2-dodecanoyloxy-3-hexacosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCC; INCHI = InChI=1S/C46H92NO8P/c1-6-8-10-12-14-16-17-18-19-20-21-22-23-24-25-26-27-28-29-31-32-34-36-38-45(48)52-42-44(43-54-56(50,51)53-41-40-47(3,4)5)55-46(49)39-37-35-33-30-15-13-11-9-7-2/h44H,6-43H2,1-5H3; MESH = Phosphatidylcholines; LMID = LMGP01011185","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.aa.C38.3","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC aa C38:3","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 812.1507; MOLECULARFORMULA = C46H86NO8P; KEGG = ; MOLECULE = C(20:3;8Z,11Z,14Z-trienoyl/18:0) aa L-Phosphatidylcholine; CAS = ; INCHIKEY = VGSUMLIRUGDCTF-NSMRCOLJSA-N; HMDB = HMDB08047           ; CHEBI = ; IUPAC = [(2R)-2-[(8Z,11Z,14Z)-icosa-8,11,14-trienoyl]oxy-3-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCC/C=C\C/C=C\C/C=C\CCCCC; INCHI = InChI=1S/C46H86NO8P/c1-6-8-10-12-14-16-18-20-22-23-25-27-29-31-33-35-37-39-46(49)55-44(43-54-56(50,51)53-41-40-47(3,4)5)42-52-45(48)38-36-34-32-30-28-26-24-21-19-17-15-13-11-9-7-2/h14,16,20,22,25,27,44H,6-13,15,17-19,21,23-24,26,28-43H2,1-5H3/b16-14-,22-20-,27-25-/t44-/m1/s1; MESH = Phosphatidylcholines; LMID = LMGP01010799","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.aa.C38.4","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC aa C38:4","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 810.13482; MOLECULARFORMULA = C46H84NO8P; KEGG = ; MOLECULE = C(20:4;5E,8E,11E,14E-tetraenoyl/18:0) aa Phosphatidylcholine; CAS = ; INCHIKEY = PSVRFUPOQYJOOZ-ADTCAWDJSA-N; HMDB = ; CHEBI = ; IUPAC = [2-[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]oxy-3-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCC/C=C/C/C=C/C/C=C/C/C=C/CCCCC; INCHI = InChI=1S/C46H84NO8P/c1-6-8-10-12-14-16-18-20-22-23-25-27-29-31-33-35-37-39-46(49)55-44(43-54-56(50,51)53-41-40-47(3,4)5)42-52-45(48)38-36-34-32-30-28-26-24-21-19-17-15-13-11-9-7-2/h14,16,20,22,25,27,31,33,44H,6-13,15,17-19,21,23-24,26,28-30,32,34-43H2,1-5H3/b16-14+,22-20+,27-25+,33-31+; MESH = Phosphatidylcholines; LMID = LMGP01010801","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.aa.C38.5","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC aa C38:5","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 808.11894; MOLECULARFORMULA = C46H82NO8P; KEGG = ; MOLECULE = C(20:4;5Z,8Z,11Z,14Z-tetraenoyl/18:1;9Z-enoyl) aa L-Phosphatidylcholine; CAS = ; INCHIKEY = ZAYXPDDGEIJGGW-VSDNDEBUSA-N; HMDB = HMDB08114           ; CHEBI = ; IUPAC = [(2R)-2-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyl]oxy-3-[(Z)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC; INCHI = InChI=1S/C46H82NO8P/c1-6-8-10-12-14-16-18-20-22-23-25-27-29-31-33-35-37-39-46(49)55-44(43-54-56(50,51)53-41-40-47(3,4)5)42-52-45(48)38-36-34-32-30-28-26-24-21-19-17-15-13-11-9-7-2/h14,16,20-22,24-25,27,31,33,44H,6-13,15,17-19,23,26,28-30,32,34-43H2,1-5H3/b16-14-,22-20-,24-21-,27-25-,33-31-/t44-/m1/s1; MESH = Phosphatidylcholines; LMID = LMGP01010905","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.aa.C38.6","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC aa C38:6","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 806.10306; MOLECULARFORMULA = C46H80NO8P; KEGG = ; MOLECULE = C(16:0/22:6;4Z,7Z,10Z,13Z,16Z,19Z-hexaenoyl) aa L-Phosphatidylcholine; CAS = ; INCHIKEY = YALZVLCVXOASDL-FZGNBNATSA-N; HMDB = HMDB08725           ; CHEBI = ; IUPAC = [(2R)-3-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-2-hexadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)COP(=O)([O-])OCC[N+](C)(C)C; INCHI = InChI=1S/C46H80NO8P/c1-6-8-10-12-14-16-18-20-21-22-23-24-25-27-28-30-32-34-36-38-45(48)52-42-44(43-54-56(50,51)53-41-40-47(3,4)5)55-46(49)39-37-35-33-31-29-26-19-17-15-13-11-9-7-2/h8,10,14,16,20-21,23-24,27-28,32,34,44H,6-7,9,11-13,15,17-19,22,25-26,29-31,33,35-43H2,1-5H3/b10-8-,16-14-,21-20-,24-23-,28-27-,34-32-/t44-/m1/s1; MESH = Phosphatidylcholines; LMID = LMGP01011116","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.aa.C40.1","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC aa C40:1","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 844.23562; MOLECULARFORMULA = C48H94NO8P; KEGG = ; MOLECULE = C(20:1;11Z-enoyl/20:0) aa L-Phosphatidylcholine; CAS = ; INCHIKEY = BUESVEVOCVSHOF-CRPILRSJSA-N; HMDB = HMDB08275           ; CHEBI = ; IUPAC = [(2R)-3-icosanoyloxy-2-[(Z)-icos-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCC/C=C\CCCCCCCC; INCHI = InChI=1S/C48H94NO8P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-38-40-47(50)54-44-46(45-56-58(52,53)55-43-42-49(3,4)5)57-48(51)41-39-37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h21,23,46H,6-20,22,24-45H2,1-5H3/b23-21-/t46-/m1/s1; MESH = Phosphatidylcholines; LMID = LMGP01011017","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.aa.C40.2","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC aa C40:2","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 842.21974; MOLECULARFORMULA = C48H92NO8P; KEGG = ; MOLECULE = C(20:1;9E-enoyl/20:1;9E-enoyl) aa L-Phosphatidylcholine; CAS = ; INCHIKEY = BCEBUGJWWZQUNZ-UHRNCNTMSA-N; HMDB = ; CHEBI = ; IUPAC = [(2R)-2,3-bis[[(E)-icos-9-enoyl]oxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCC/C=C/CCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCC/C=C/CCCCCCCCCC; INCHI = InChI=1S/C48H92NO8P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-38-40-47(50)54-44-46(45-56-58(52,53)55-43-42-49(3,4)5)57-48(51)41-39-37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h24-27,46H,6-23,28-45H2,1-5H3/b26-24+,27-25+/t46-/m1/s1; MESH = Phosphatidylcholines; LMID = LMGP01011042","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.aa.C40.3","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC aa C40:3","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 840.20386; MOLECULARFORMULA = C48H90NO8P; KEGG = C00157; MOLECULE = C(20:3;11Z,14Z.17Z-trienoyl/20:0) aa L-Phosphatidylcholine; CAS = ; INCHIKEY = REABNEVSLLNWCN-NEUZZYPFSA-N; HMDB = ; CHEBI = ; IUPAC = [(2R)-3-icosanoyloxy-2-[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCC/C=C\C/C=C\C/C=C\CC; INCHI = InChI=1S/C48H90NO8P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-38-40-47(50)54-44-46(45-56-58(52,53)55-43-42-49(3,4)5)57-48(51)41-39-37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h9,11,15,17,21,23,46H,6-8,10,12-14,16,18-20,22,24-45H2,1-5H3/b11-9-,17-15-,23-21-/t46-/m1/s1; MESH = Phosphatidylcholines; LMID = LMGP01011022","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.aa.C40.4","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC aa C40:4","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 838.18798; MOLECULARFORMULA = C48H88NO8P; KEGG = ; MOLECULE = C(20:4;5Z,8Z,11Z,14Z-tetraenoyl/20:0) aa L-Phosphatidylcholine; CAS = ; INCHIKEY = UAVRPIXHIHJERN-CBTSKTMBSA-N; HMDB = HMDB08279           ; CHEBI = ; IUPAC = [(2R)-3-icosanoyloxy-2-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC; INCHI = InChI=1S/C48H88NO8P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-38-40-47(50)54-44-46(45-56-58(52,53)55-43-42-49(3,4)5)57-48(51)41-39-37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h15,17,21,23,27,29,33,35,46H,6-14,16,18-20,22,24-26,28,30-32,34,36-45H2,1-5H3/b17-15-,23-21-,29-27-,35-33-/t46-/m1/s1; MESH = Phosphatidylcholines; LMID = LMGP01011023","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.aa.C40.5","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC aa C40:5","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 836.1721; MOLECULARFORMULA = C48H86NO8P; KEGG = ; MOLECULE = C(22:4;7Z,10Z,13Z,16Z,19Z-tetraenoyl/18:1;9Z-enoyl) aa Phosphatidylcholine; CAS = ; INCHIKEY = RNPXVUWNKQBTRY-ZFEATTIUSA-N; HMDB = HMDB08120           ; CHEBI = ; IUPAC = [2-[(7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoyl]oxy-3-[(Z)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCC/C=C\CCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC; INCHI = InChI=1S/C48H86NO8P/c1-6-8-10-12-14-16-18-20-22-23-24-25-27-29-31-33-35-37-39-41-48(51)57-46(45-56-58(52,53)55-43-42-49(3,4)5)44-54-47(50)40-38-36-34-32-30-28-26-21-19-17-15-13-11-9-7-2/h14,16,20-22,24-26,29,31,46H,6-13,15,17-19,23,27-28,30,32-45H2,1-5H3/b16-14-,22-20-,25-24-,26-21-,31-29-; MESH = Phosphatidylcholines; LMID = LMGP01010911","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.aa.C40.6","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC aa C40:6","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 834.15622; MOLECULARFORMULA = C48H84NO8P; KEGG = ; MOLECULE = C(22:5;7Z,10Z,13Z,16Z,19Z-pentaenoyl/18:1;11Z-enoyl) aa L-Phosphatidylcholine; CAS = ; INCHIKEY = FYVNIFOYDIIODX-KNKJIUSSSA-N; HMDB = HMDB08089           ; CHEBI = ; IUPAC = [(2R)-2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-[(Z)-octadec-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCC/C=C\CCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC; INCHI = InChI=1S/C48H84NO8P/c1-6-8-10-12-14-16-18-20-22-23-24-25-27-29-31-33-35-37-39-41-48(51)57-46(45-56-58(52,53)55-43-42-49(3,4)5)44-54-47(50)40-38-36-34-32-30-28-26-21-19-17-15-13-11-9-7-2/h8,10,14,16-17,19-20,22,24-25,29,31,46H,6-7,9,11-13,15,18,21,23,26-28,30,32-45H2,1-5H3/b10-8-,16-14-,19-17-,22-20-,25-24-,31-29-/t46-/m1/s1; MESH = Phosphatidylcholines; LMID = LMGP01010846","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.aa.C42.0","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC aa C42:0","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 874.30466; MOLECULARFORMULA = C50H100NO8P; KEGG = ; MOLECULE = C(16:0/26:0) aa L-Phosphatidylcholine; CAS = ; INCHIKEY = QVBFTGNVCXTNOX-UHFFFAOYSA-N; HMDB = ; CHEBI = ; IUPAC = (3-hexacosanoyloxy-2-hexadecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC; INCHI = InChI=1S/C50H100NO8P/c1-6-8-10-12-14-16-18-20-21-22-23-24-25-26-27-28-29-31-32-34-36-38-40-42-49(52)56-46-48(47-58-60(54,55)57-45-44-51(3,4)5)59-50(53)43-41-39-37-35-33-30-19-17-15-13-11-9-7-2/h48H,6-47H2,1-5H3; MESH = Phosphatidylcholines; LMID = LMGP01011189","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.aa.C42.1","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC aa C42:1","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 872.28878; MOLECULARFORMULA = C50H98NO8P; KEGG = ; MOLECULE = C(18:1;6Z-enoyl/24:0) aa L-Phosphatidylcholine; CAS = ; INCHIKEY = KHMWGVYTWZITJW-YGYGMDEDSA-N; HMDB = ; CHEBI = ; IUPAC = [(2R)-2-[(Z)-octadec-6-enoyl]oxy-3-tetracosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCC/C=C\CCCCCCCCCCC; INCHI = InChI=1S/C50H98NO8P/c1-6-8-10-12-14-16-18-20-22-23-24-25-26-27-29-30-32-34-36-38-40-42-49(52)56-46-48(47-58-60(54,55)57-45-44-51(3,4)5)59-50(53)43-41-39-37-35-33-31-28-21-19-17-15-13-11-9-7-2/h33,35,48H,6-32,34,36-47H2,1-5H3/b35-33-/t48-/m1/s1; MESH = Phosphatidylcholines; LMID = LMGP01011151","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.aa.C42.2","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC aa C42:2","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 870.2729; MOLECULARFORMULA = C50H96NO8P; KEGG = C00157; MOLECULE = C(26:2;5Z,9Z-dienoyl/16:0) aa L-Phosphatidylcholine; CAS = ; INCHIKEY = ITFWNTFYLTWDNT-DDPSORSSSA-N; HMDB = ; CHEBI = ; IUPAC = [(2R)-2-[(5Z,9Z)-hexacosa-5,9-dienoyl]oxy-3-hexadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCC/C=C\CC/C=C\CCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C; INCHI = InChI=1S/C50H96NO8P/c1-6-8-10-12-14-16-18-20-21-22-23-24-25-26-27-28-29-31-33-35-37-39-41-43-50(53)59-48(47-58-60(54,55)57-45-44-51(3,4)5)46-56-49(52)42-40-38-36-34-32-30-19-17-15-13-11-9-7-2/h28-29,35,37,48H,6-27,30-34,36,38-47H2,1-5H3/b29-28-,37-35-/t48-/m1/s1; MESH = Phosphatidylcholines; LMID = LMGP01010665","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.aa.C42.4","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC aa C42:4","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 866.2498; MOLECULARFORMULA = C50H92NO8P; KEGG = C00157; MOLECULE = Phosphatidylcholine with diacyl residue sum C42:4; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = ; ISOMERIC = ; INCHI = ; MESH = Phosphatidylcholines; LMID = LMGP01010000","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.aa.C42.5","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC aa C42:5","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 864.22526; MOLECULARFORMULA = C50H90NO8P; KEGG = C00157; MOLECULE = C(22:1;7Z,10Z,13Z,16Z,19Z-pentanoyl/20:0) aa L-Phosphatidylcholine; CAS = ; INCHIKEY = SGYNBRXEOXADHS-CIUHTZMDSA-N; HMDB = HMDB08287           ; CHEBI = ; IUPAC = [(2R)-2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-icosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC; INCHI = InChI=1S/C50H90NO8P/c1-6-8-10-12-14-16-18-20-22-24-25-27-29-31-33-35-37-39-41-43-50(53)59-48(47-58-60(54,55)57-45-44-51(3,4)5)46-56-49(52)42-40-38-36-34-32-30-28-26-23-21-19-17-15-13-11-9-7-2/h8,10,14,16,20,22,25,27,31,33,48H,6-7,9,11-13,15,17-19,21,23-24,26,28-30,32,34-47H2,1-5H3/b10-8-,16-14-,22-20-,27-25-,33-31-/t48-/m1/s1; MESH = Phosphatidylcholines; LMID = LMGP01011027","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.aa.C42.6","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC aa C42:6","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 862.20938; MOLECULARFORMULA = C50H88NO8P; KEGG = ; MOLECULE = C(22:1;4Z,7Z,10Z,13Z,16Z,19Z-pentanoyl/20:0) aa L-Phosphatidylcholine; CAS = ; INCHIKEY = WAFWSBFKIPCFOF-ZDAJSWCOSA-N; HMDB = HMDB08288           ; CHEBI = ; IUPAC = [(2R)-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-icosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC; INCHI = InChI=1S/C50H88NO8P/c1-6-8-10-12-14-16-18-20-22-24-25-27-29-31-33-35-37-39-41-43-50(53)59-48(47-58-60(54,55)57-45-44-51(3,4)5)46-56-49(52)42-40-38-36-34-32-30-28-26-23-21-19-17-15-13-11-9-7-2/h8,10,14,16,20,22,25,27,31,33,37,39,48H,6-7,9,11-13,15,17-19,21,23-24,26,28-30,32,34-36,38,40-47H2,1-5H3/b10-8-,16-14-,22-20-,27-25-,33-31-,39-37-/t48-/m1/s1; MESH = Phosphatidylcholines; LMID = LMGP01011028","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.ae.C30.0","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC ae C30:0","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 692.00218; MOLECULARFORMULA = C38H78NO7P; KEGG = ; MOLECULE = C(16:0/e14:0) ae L-Phosphatidylcholine; CAS = ; INCHIKEY = BYMZZQJJOHDZOU-DIPNUNPCSA-N; HMDB = ; CHEBI = ; IUPAC = [(2R)-2-hexadecanoyloxy-3-tetradecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCC(=O)O[C@H](COCCCCCCCCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C; INCHI = InChI=1S/C38H78NO7P/c1-6-8-10-12-14-16-18-20-21-23-25-27-29-31-38(40)46-37(36-45-47(41,42)44-34-32-39(3,4)5)35-43-33-30-28-26-24-22-19-17-15-13-11-9-7-2/h37H,6-36H2,1-5H3/t37-/m1/s1; MESH = Phosphatidylcholines; LMID = LMGP01020012","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.ae.C30.1","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC ae C30:1","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 689.9863; MOLECULARFORMULA = C38H76NO7P; KEGG = ; MOLECULE = C(16:1;9Z-enoyl/e14:0) ae L-Phosphatidylcholine; CAS = ; INCHIKEY = ZCNUNZUDXNSNRZ-WTWBAFHPSA-N; HMDB = ; CHEBI = ; IUPAC = [(2R)-2-[(Z)-hexadec-9-enoyl]oxy-3-tetradecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCOC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCC/C=C\CCCCCC; INCHI = InChI=1S/C38H76NO7P/c1-6-8-10-12-14-16-18-20-21-23-25-27-29-31-38(40)46-37(36-45-47(41,42)44-34-32-39(3,4)5)35-43-33-30-28-26-24-22-19-17-15-13-11-9-7-2/h16,18,37H,6-15,17,19-36H2,1-5H3/b18-16-/t37-/m1/s1; MESH = Phosphatidylcholines; LMID = LMGP01020014","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.ae.C30.2","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC ae C30:2","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 687.9766; MOLECULARFORMULA = C38H74NO7P; KEGG = ; MOLECULE = Phosphatidylcholine with acyl-alkyl residue sum C30:2; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = ; ISOMERIC = ; INCHI = ; MESH = Phosphatidylcholines; LMID = LMGP01020000","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.ae.C32.1","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC ae C32:1","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 718.03946; MOLECULARFORMULA = C40H80NO7P; KEGG = ; MOLECULE = C(18:1;9Z-enoyl/e14:0) ae L-Phosphatidylcholine; CAS = ; INCHIKEY = KKCGBTJTPQETOY-KUNNKMQBSA-N; HMDB = ; CHEBI = ; IUPAC = [(2R)-2-[(Z)-octadec-9-enoyl]oxy-3-tetradecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCOC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCC/C=C\CCCCCCCC; INCHI = InChI=1S/C40H80NO7P/c1-6-8-10-12-14-16-18-20-21-22-23-25-27-29-31-33-40(42)48-39(38-47-49(43,44)46-36-34-41(3,4)5)37-45-35-32-30-28-26-24-19-17-15-13-11-9-7-2/h20-21,39H,6-19,22-38H2,1-5H3/b21-20-/t39-/m1/s1; MESH = Phosphatidylcholines; LMID = LMGP01020016","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.ae.C32.2","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC ae C32:2","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 716.02358; MOLECULARFORMULA = C40H78NO7P; KEGG = ; MOLECULE = C(18:1;9Z-enoyl/e14:1;1Z-en) ae L-Phosphatidylcholine; CAS = ; INCHIKEY = CDELFBJJHZJURR-JDTLOSAXSA-N; HMDB = ; CHEBI = ; IUPAC = [(2R)-2-[(Z)-octadec-9-enoyl]oxy-3-[(Z)-tetradec-1-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCC/C=C\OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCC/C=C\CCCCCCCC; INCHI = InChI=1S/C40H78NO7P/c1-6-8-10-12-14-16-18-20-21-22-23-25-27-29-31-33-40(42)48-39(38-47-49(43,44)46-36-34-41(3,4)5)37-45-35-32-30-28-26-24-19-17-15-13-11-9-7-2/h20-21,32,35,39H,6-19,22-31,33-34,36-38H2,1-5H3/b21-20-,35-32-/t39-/m1/s1; MESH = Phosphatidylcholines; LMID = LMGP01030004","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.ae.C34.0","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC ae C34:0","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 748.1085; MOLECULARFORMULA = C42H86NO7P; KEGG = ; MOLECULE = C(16:0/e18:0) ae D-Phosphatidylcholine; CAS = ; INCHIKEY = GTFLTTXDLGEBAI-RWYGWLOXSA-N; HMDB = ; CHEBI = ; IUPAC = [(2S)-2-hexadecanoyloxy-3-octadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCCCCOC[C@@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC; INCHI = InChI=1S/C42H86NO7P/c1-6-8-10-12-14-16-18-20-21-22-24-26-28-30-32-34-37-47-39-41(40-49-51(45,46)48-38-36-43(3,4)5)50-42(44)35-33-31-29-27-25-23-19-17-15-13-11-9-7-2/h41H,6-40H2,1-5H3/t41-/m0/s1; MESH = Phosphatidylcholines; LMID = LMGP01020087","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.ae.C34.1","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC ae C34:1","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 746.09262; MOLECULARFORMULA = C42H84NO7P; KEGG = ; MOLECULE = C(16:0;e18:1;9Z-en) ae Phosphatidylcholine; CAS = ; INCHIKEY = IQLHTKSHLGLPMG-MRCUWXFGSA-N; HMDB = ; CHEBI = ; IUPAC = [2-hexadecanoyloxy-3-[(Z)-octadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCC(=O)OC(COCCCCCCCC/C=C\CCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C; INCHI = InChI=1S/C42H84NO7P/c1-6-8-10-12-14-16-18-20-21-22-24-26-28-30-32-34-37-47-39-41(40-49-51(45,46)48-38-36-43(3,4)5)50-42(44)35-33-31-29-27-25-23-19-17-15-13-11-9-7-2/h20-21,41H,6-19,22-40H2,1-5H3/b21-20-; MESH = Phosphatidylcholines; LMID = LMGP01020153","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.ae.C34.2","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC ae C34:2","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 744.07674; MOLECULARFORMULA = C42H82NO7P; KEGG = ; MOLECULE = C(18:1;9Z,12Z-dienoyl/e16:0) ae L-Phosphatidylcholine; CAS = ; INCHIKEY = IQACMFWAGALEAQ-WESJWMGVSA-N; HMDB = HMDB11151           ; CHEBI = ; IUPAC = [(2R)-3-hexadecoxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCCOC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC; INCHI = InChI=1S/C42H82NO7P/c1-6-8-10-12-14-16-18-20-22-23-25-27-29-31-33-35-42(44)50-41(40-49-51(45,46)48-38-36-43(3,4)5)39-47-37-34-32-30-28-26-24-21-19-17-15-13-11-9-7-2/h14,16,20,22,41H,6-13,15,17-19,21,23-40H2,1-5H3/b16-14-,22-20-/t41-/m1/s1; MESH = Phosphatidylcholines; LMID = LMGP01020039","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.ae.C34.3","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC ae C34:3","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 742.06086; MOLECULARFORMULA = C42H80NO7P; KEGG = ; MOLECULE = C(18:1;6Z,9Z,12Z-trienoyl/e16:0) ae L-Phosphatidylcholine; CAS = ; INCHIKEY = QEWRXEALGMKRGP-MZWPLUPDSA-N; HMDB = ; CHEBI = ; IUPAC = [(2R)-3-hexadecoxy-2-[(6Z,9Z,12Z)-octadeca-6,9,12-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCCOC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCC/C=C\C/C=C\C/C=C\CCCCC; INCHI = InChI=1S/C42H80NO7P/c1-6-8-10-12-14-16-18-20-22-23-25-27-29-31-33-35-42(44)50-41(40-49-51(45,46)48-38-36-43(3,4)5)39-47-37-34-32-30-28-26-24-21-19-17-15-13-11-9-7-2/h14,16,20,22,25,27,41H,6-13,15,17-19,21,23-24,26,28-40H2,1-5H3/b16-14-,22-20-,27-25-/t41-/m1/s1; MESH = Phosphatidylcholines; LMID = LMGP01020041","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.ae.C36.0","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC ae C36:0","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 776.16166; MOLECULARFORMULA = C44H90NO7P; KEGG = ; MOLECULE = C(18:0/e18:0) ae D-Phosphatidylcholine; CAS = ; INCHIKEY = BKEDGKIMIUGHDV-QLKFWGTOSA-N; HMDB = ; CHEBI = ; IUPAC = [(2S)-2-octadecanoyloxy-3-octadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCCCCOC[C@@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC; INCHI = InChI=1S/C44H90NO7P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-39-49-41-43(42-51-53(47,48)50-40-38-45(3,4)5)52-44(46)37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h43H,6-42H2,1-5H3/t43-/m0/s1; MESH = Phosphatidylcholines; LMID = LMGP01020092","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.ae.C36.1","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC ae C36:1","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 774.14578; MOLECULARFORMULA = C44H88NO7P; KEGG = ; MOLECULE = C(20:1;9Z-enoyl/e16:0) ae L-Phosphatidylcholine; CAS = ; INCHIKEY = KDJNGPJWWLDTBH-IJPQMANRSA-N; HMDB = ; CHEBI = ; IUPAC = [(2R)-3-hexadecoxy-2-[(Z)-icos-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCCOC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCC/C=C\CCCCCCCCCC; INCHI = InChI=1S/C44H88NO7P/c1-6-8-10-12-14-16-18-20-22-23-24-25-27-29-31-33-35-37-44(46)52-43(42-51-53(47,48)50-40-38-45(3,4)5)41-49-39-36-34-32-30-28-26-21-19-17-15-13-11-9-7-2/h23-24,43H,6-22,25-42H2,1-5H3/b24-23-/t43-/m1/s1; MESH = Phosphatidylcholines; LMID = LMGP01020052","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.ae.C36.2","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC ae C36:2","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 772.1299; MOLECULARFORMULA = C44H86NO7P; KEGG = ; MOLECULE = C(18:1;9Z-enoyl/e18:1;1Z-en) ae L-Phosphatidylcholine; CAS = ; INCHIKEY = DSWOVBIRJNAJAF-NVJOKYTBSA-N; HMDB = HMDB11243           ; CHEBI = ; IUPAC = [(2R)-3-[(Z)-octadec-1-enoxy]-2-[(Z)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCC/C=C\OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCC/C=C\CCCCCCCC; INCHI = InChI=1S/C44H86NO7P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-39-49-41-43(42-51-53(47,48)50-40-38-45(3,4)5)52-44(46)37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h21,23,36,39,43H,6-20,22,24-35,37-38,40-42H2,1-5H3/b23-21-,39-36-/t43-/m1/s1; MESH = Phosphatidylcholines; LMID = LMGP01030013","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.ae.C36.3","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC ae C36:3","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 770.11402; MOLECULARFORMULA = C44H84NO7P; KEGG = ; MOLECULE = C(20:3;8Z,11Z,14Z-trienoyl/e16:0) ae L-Phosphatidylcholine; CAS = ; INCHIKEY = VYKSGWCIVDQIQR-MEAIPJDCSA-N; HMDB = ; CHEBI = ; IUPAC = [(2R)-3-hexadecoxy-2-[(8Z,11Z,14Z)-icosa-8,11,14-trienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCCOC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCC/C=C\C/C=C\C/C=C\CCCCC; INCHI = InChI=1S/C44H84NO7P/c1-6-8-10-12-14-16-18-20-22-23-24-25-27-29-31-33-35-37-44(46)52-43(42-51-53(47,48)50-40-38-45(3,4)5)41-49-39-36-34-32-30-28-26-21-19-17-15-13-11-9-7-2/h14,16,20,22,24-25,43H,6-13,15,17-19,21,23,26-42H2,1-5H3/b16-14-,22-20-,25-24-/t43-/m1/s1; MESH = Phosphatidylcholines; LMID = LMGP01020053","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.ae.C36.4","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC ae C36:4","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 768.09814; MOLECULARFORMULA = C44H82NO7P; KEGG = ; MOLECULE = C(20:4;5E,8E,11E,14E-tetraenoyl/e16:0) ae L-Phosphatidylcholine; CAS = ; INCHIKEY = DUUSFCFZBREELS-SEHARXJXSA-N; HMDB = ; CHEBI = ; IUPAC = [(2R)-3-hexadecoxy-2-[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCCOC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCC/C=C/C/C=C/C/C=C/C/C=C/CCCCC; INCHI = InChI=1S/C44H82NO7P/c1-6-8-10-12-14-16-18-20-22-23-24-25-27-29-31-33-35-37-44(46)52-43(42-51-53(47,48)50-40-38-45(3,4)5)41-49-39-36-34-32-30-28-26-21-19-17-15-13-11-9-7-2/h14,16,20,22,24-25,29,31,43H,6-13,15,17-19,21,23,26-28,30,32-42H2,1-5H3/b16-14+,22-20+,25-24+,31-29+/t43-/m1/s1; MESH = Phosphatidylcholines; LMID = LMGP01020054","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.ae.C36.5","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC ae C36:5","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 766.08226; MOLECULARFORMULA = C44H80NO7P; KEGG = ; MOLECULE = C(20:4;5Z,8Z,11Z,14Z-tetraenoyl/e16:1;1Z-en) ae L-Phosphatidylcholine; CAS = ; INCHIKEY = IOYKZPNDXIIXLN-LOQSCQKMSA-N; HMDB = HMDB11220           ; CHEBI = ; IUPAC = [(2R)-3-[(Z)-hexadec-1-enoxy]-2-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCC/C=C\OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC; INCHI = InChI=1S/C44H80NO7P/c1-6-8-10-12-14-16-18-20-22-23-24-25-27-29-31-33-35-37-44(46)52-43(42-51-53(47,48)50-40-38-45(3,4)5)41-49-39-36-34-32-30-28-26-21-19-17-15-13-11-9-7-2/h14,16,20,22,24-25,29,31,36,39,43H,6-13,15,17-19,21,23,26-28,30,32-35,37-38,40-42H2,1-5H3/b16-14-,22-20-,25-24-,31-29-,39-36-/t43-/m1/s1; MESH = Phosphatidylcholines; LMID = LMGP01030010","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.ae.C38.0","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC ae C38:0","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 804.21482; MOLECULARFORMULA = C46H94NO7P; KEGG = ; MOLECULE = C(20:0/e18:0) ae L-Phosphatidylcholine; CAS = ; INCHIKEY = BVCZSMAYNCVQDT-WBVITSLISA-N; HMDB = ; CHEBI = ; IUPAC = [(2R)-2-icosanoyloxy-3-octadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COCCCCCCCCCCCCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C; INCHI = InChI=1S/C46H94NO7P/c1-6-8-10-12-14-16-18-20-22-24-25-27-29-31-33-35-37-39-46(48)54-45(44-53-55(49,50)52-42-40-47(3,4)5)43-51-41-38-36-34-32-30-28-26-23-21-19-17-15-13-11-9-7-2/h45H,6-44H2,1-5H3/t45-/m1/s1; MESH = Phosphatidylcholines; LMID = LMGP01020097","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.ae.C38.1","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC ae C38:1","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 802.19894; MOLECULARFORMULA = C46H92NO7P; KEGG = ; MOLECULE = C(20:1;9Z-enoyl/e18:0) ae L-Phosphatidylcholine; CAS = ; INCHIKEY = DBNUPYDJSILSJX-VABJTFOOSA-N; HMDB = ; CHEBI = ; IUPAC = [(2R)-2-[(Z)-icos-9-enoyl]oxy-3-octadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCCCCOC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCC/C=C\CCCCCCCCCC; INCHI = InChI=1S/C46H92NO7P/c1-6-8-10-12-14-16-18-20-22-24-25-27-29-31-33-35-37-39-46(48)54-45(44-53-55(49,50)52-42-40-47(3,4)5)43-51-41-38-36-34-32-30-28-26-23-21-19-17-15-13-11-9-7-2/h24-25,45H,6-23,26-44H2,1-5H3/b25-24-/t45-/m1/s1; MESH = Phosphatidylcholines; LMID = LMGP01020099","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.ae.C38.2","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC ae C38:2","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 800.191; MOLECULARFORMULA = C46H90NO7P; KEGG = ; MOLECULE = Phosphatidylcholine with acyl-alkyl residue sum C38:2; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = ; ISOMERIC = ; INCHI = ; MESH = Phosphatidylcholines; LMID = LMGP01020000","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.ae.C38.3","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC ae C38:3","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 798.1752; MOLECULARFORMULA = C46H88NO7P; KEGG = ; MOLECULE = PC ae C38:3; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = ; ISOMERIC = ; INCHI = ; MESH = Phosphatidylcholines; LMID = LMGP01020000","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.ae.C38.4","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC ae C38:4","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 796.1513; MOLECULARFORMULA = C46H86NO7P; KEGG = ; MOLECULE = C(20:4;5Z,8Z,11Z,14Z-tetraenoyl/e18:0) ae L-Phosphatidylcholine; CAS = ; INCHIKEY = GBNPCIWXLWZJGA-IGBSIYCFSA-N; HMDB = ; CHEBI = ; IUPAC = [(2R)-2-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyl]oxy-3-octadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCCCCOC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC; INCHI = InChI=1S/C46H86NO7P/c1-6-8-10-12-14-16-18-20-22-24-25-27-29-31-33-35-37-39-46(48)54-45(44-53-55(49,50)52-42-40-47(3,4)5)43-51-41-38-36-34-32-30-28-26-23-21-19-17-15-13-11-9-7-2/h14,16,20,22,25,27,31,33,45H,6-13,15,17-19,21,23-24,26,28-30,32,34-44H2,1-5H3/b16-14-,22-20-,27-25-,33-31-/t45-/m1/s1; MESH = Phosphatidylcholines; LMID = LMGP01020102","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.ae.C38.5","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC ae C38:5","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 794.13542; MOLECULARFORMULA = C46H84NO7P; KEGG = ; MOLECULE = C(20:4;(5Z,8Z,11Z,14Z-tetraenoyl/e18:1;9Z-en) ae L-Phosphatidylcholine; CAS = ; INCHIKEY = VJNPDLZENXBRLB-MQEDXBOASA-N; HMDB = ; CHEBI = ; IUPAC = [(2R)-2-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyl]oxy-3-[(Z)-octadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCC/C=C\CCCCCCCCOC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC; INCHI = InChI=1S/C46H84NO7P/c1-6-8-10-12-14-16-18-20-22-24-25-27-29-31-33-35-37-39-46(48)54-45(44-53-55(49,50)52-42-40-47(3,4)5)43-51-41-38-36-34-32-30-28-26-23-21-19-17-15-13-11-9-7-2/h14,16,20-23,25,27,31,33,45H,6-13,15,17-19,24,26,28-30,32,34-44H2,1-5H3/b16-14-,22-20-,23-21-,27-25-,33-31-/t45-/m1/s1; MESH = Phosphatidylcholines; LMID = LMGP01020157","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.ae.C38.6","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC ae C38:6","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 792.11954; MOLECULARFORMULA = C46H82NO7P; KEGG = ; MOLECULE = C(22:6;4Z,7Z,10Z,13Z,16Z,19Z-pentaenoyl/e16:0) ae L-Phosphatidylcholine; CAS = ; INCHIKEY = QQQQNYAHSSIZBU-HIQXTUQZSA-N; HMDB = ; CHEBI = ; IUPAC = [(2R)-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-hexadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCCOC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC; INCHI = InChI=1S/C46H82NO7P/c1-6-8-10-12-14-16-18-20-22-23-24-25-26-27-29-31-33-35-37-39-46(48)54-45(44-53-55(49,50)52-42-40-47(3,4)5)43-51-41-38-36-34-32-30-28-21-19-17-15-13-11-9-7-2/h8,10,14,16,20,22,24-25,27,29,33,35,45H,6-7,9,11-13,15,17-19,21,23,26,28,30-32,34,36-44H2,1-5H3/b10-8-,16-14-,22-20-,25-24-,29-27-,35-33-/t45-/m1/s1; MESH = Phosphatidylcholines; LMID = LMGP01020064","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.ae.C40.1","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC ae C40:1","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 830.2604; MOLECULARFORMULA = C48H96NO7P; KEGG = ; MOLECULE = Phosphatidylcholine with acyl-alkyl residue sum C40:1; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = ; ISOMERIC = ; INCHI = ; MESH = Phosphatidylcholines; LMID = LMGP01020000","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.ae.C40.2","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC ae C40:2","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 828.2446; MOLECULARFORMULA = C48H94NO7P; KEGG = ; MOLECULE = Phosphatidylcholine with acyl-alkyl residue sum C40:2; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = ; ISOMERIC = ; INCHI = ; MESH = Phosphatidylcholines; LMID = LMGP01020000","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.ae.C40.3","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC ae C40:3","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 826.2288; MOLECULARFORMULA = C48H92NO7P; KEGG = ; MOLECULE = Phosphatidylcholine with acyl-alkyl residue sum C40:3; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = ; ISOMERIC = ; INCHI = ; MESH = Phosphatidylcholines; LMID = LMGP01020000","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.ae.C40.4","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC ae C40:4","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 824.213; MOLECULARFORMULA = C48H90NO7P; KEGG = ; MOLECULE = Phosphatidylcholine with acyl-alkyl residue sum C40:4; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = ; ISOMERIC = ; INCHI = ; MESH = Phosphatidylcholines; LMID = LMGP01020000","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.ae.C40.5","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC ae C40:5","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 822.18858; MOLECULARFORMULA = C48H88NO7P; KEGG = ; MOLECULE = C(22:5;4Z,7Z,10Z,13Z,16Z-pentaenoyl/e18:0) ae L-Phosphatidylcholine; CAS = ; INCHIKEY = KDRRVBBVKZQQTN-BEBRKXFFSA-N; HMDB = ; CHEBI = ; IUPAC = [(2R)-2-[(4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoyl]oxy-3-octadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCCCCOC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC; INCHI = InChI=1S/C48H88NO7P/c1-6-8-10-12-14-16-18-20-22-24-25-26-27-29-31-33-35-37-39-41-48(50)56-47(46-55-57(51,52)54-44-42-49(3,4)5)45-53-43-40-38-36-34-32-30-28-23-21-19-17-15-13-11-9-7-2/h14,16,20,22,25-26,29,31,35,37,47H,6-13,15,17-19,21,23-24,27-28,30,32-34,36,38-46H2,1-5H3/b16-14-,22-20-,26-25-,31-29-,37-35-/t47-/m1/s1; MESH = Phosphatidylcholines; LMID = LMGP01020107","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.ae.C40.6","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC ae C40:6","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 820.1727; MOLECULARFORMULA = C48H86NO7P; KEGG = ; MOLECULE = C(22:5;4Z,7Z,10Z,13Z,16Z,19Z-hexaenoyl/e18:0) ae L-Phosphatidylcholine; CAS = ; INCHIKEY = QBZALASVZLFAHF-KYPHJRDXSA-N; HMDB = ; CHEBI = ; IUPAC = [(2R)-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-octadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCCCCOC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC; INCHI = InChI=1S/C48H86NO7P/c1-6-8-10-12-14-16-18-20-22-24-25-26-27-29-31-33-35-37-39-41-48(50)56-47(46-55-57(51,52)54-44-42-49(3,4)5)45-53-43-40-38-36-34-32-30-28-23-21-19-17-15-13-11-9-7-2/h8,10,14,16,20,22,25-26,29,31,35,37,47H,6-7,9,11-13,15,17-19,21,23-24,27-28,30,32-34,36,38-46H2,1-5H3/b10-8-,16-14-,22-20-,26-25-,31-29-,37-35-/t47-/m1/s1; MESH = Phosphatidylcholines; LMID = LMGP01020110","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.ae.C42.0","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC ae C42:0","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 860.32114; MOLECULARFORMULA = C50H102NO7P; KEGG = ; MOLECULE = C(22:0/e20:0) ae L-Phosphatidylcholine; CAS = ; INCHIKEY = BJUWREINODTBMO-ANFMRNGASA-N; HMDB = ; CHEBI = ; IUPAC = [(2R)-2-docosanoyloxy-3-icosoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COCCCCCCCCCCCCCCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C; INCHI = InChI=1S/C50H102NO7P/c1-6-8-10-12-14-16-18-20-22-24-26-27-29-31-33-35-37-39-41-43-50(52)58-49(48-57-59(53,54)56-46-44-51(3,4)5)47-55-45-42-40-38-36-34-32-30-28-25-23-21-19-17-15-13-11-9-7-2/h49H,6-48H2,1-5H3/t49-/m1/s1; MESH = Phosphatidylcholines; LMID = LMGP01020125","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.ae.C42.1","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC ae C42:1","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 858.314; MOLECULARFORMULA = C50H100NO7P; KEGG = ; MOLECULE = Phosphatidylcholine with acyl-alkyl residue sum C42:1; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = ; ISOMERIC = ; INCHI = ; MESH = Phosphatidylcholines; LMID = LMGP01020000","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.ae.C42.2","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC ae C42:2","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 856.2982; MOLECULARFORMULA = C50H98NO7P; KEGG = ; MOLECULE = Phosphatidylcholine with acyl-alkyl residue sum C42:2; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = ; ISOMERIC = ; INCHI = ; MESH = Phosphatidylcholines; LMID = LMGP01020000","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.ae.C42.3","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC ae C42:3","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 854.2824; MOLECULARFORMULA = C50H96NO7P; KEGG = ; MOLECULE = Phosphatidylcholine with acyl-alkyl residue sum C42:3; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = ; ISOMERIC = ; INCHI = ; MESH = Phosphatidylcholines; LMID = LMGP01020000","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.ae.C42.4","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC ae C42:4","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 852.2666; MOLECULARFORMULA = C50H94NO7P; KEGG = ; MOLECULE = Phosphatidylcholine with acyl-alkyl residue sum C42:4; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = ; ISOMERIC = ; INCHI = ; MESH = Phosphatidylcholines; LMID = LMGP01020000","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.ae.C42.5","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC ae C42:5","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 850.2508; MOLECULARFORMULA = C50H92NO7P; KEGG = ; MOLECULE = Phosphatidylcholine with acyl-alkyl residue sum C42:5; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = ; ISOMERIC = ; INCHI = ; MESH = Phosphatidylcholines; LMID = LMGP01020000","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.ae.C44.3","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC ae C44:3","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 882.336; MOLECULARFORMULA = C52H100NO7P; KEGG = ; MOLECULE = Phosphatidylcholine with acyl-alkyl residue sum C44:3; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = ; ISOMERIC = ; INCHI = ; MESH = Phosphatidylcholines; LMID = LMGP01020000","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.ae.C44.4","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC ae C44:4","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 880.3202; MOLECULARFORMULA = C52H98NO7P; KEGG = ; MOLECULE = Phosphatidylcholine with acyl-alkyl residue sum C44:4; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = ; ISOMERIC = ; INCHI = ; MESH = Phosphatidylcholines; LMID = LMGP01020000","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.ae.C44.5","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC ae C44:5","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 878.3044; MOLECULARFORMULA = C52H96NO7P; KEGG = ; MOLECULE = Phosphatidylcholine with acyl-alkyl residue sum C44:5; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = ; ISOMERIC = ; INCHI = ; MESH = Phosphatidylcholines; LMID = LMGP01020000","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","PC.ae.C44.6","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","PC ae C44:6","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 876.2886; MOLECULARFORMULA = C52H94NO7P; KEGG = ; MOLECULE = Phosphatidylcholine with acyl-alkyl residue sum C44:6; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = ; ISOMERIC = ; INCHI = ; MESH = Phosphatidylcholines; LMID = LMGP01020000","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","SM..OH..C14.1","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","SM (OH) C14:1","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 688.9647; MOLECULARFORMULA = C37H73N2O7P; KEGG = ; MOLECULE = Hydroxysphingomyelin with acyl residue sum C14:1; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = ; ISOMERIC = ; INCHI = ; MESH = Sphingomyelins; LMID = LMSP03010000","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","SM..OH..C16.1","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","SM (OH) C16:1","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 717.0183; MOLECULARFORMULA = C39H77N2O7P; KEGG = C00550; MOLECULE = Hydroxysphingomyelin with acyl residue sum C16:1; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = ; ISOMERIC = ; INCHI = ; MESH = Sphingomyelins; LMID = LMSP03010000","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","SM..OH..C22.1","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","SM (OH) C22:1","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 801.1791; MOLECULARFORMULA = C45H89N2O7P; KEGG = C00550; MOLECULE = Hydroxysphingomyelin with acyl residue sum C22:1; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = ; ISOMERIC = ; INCHI = ; MESH = Sphingomyelins; LMID = LMSP03010000","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","SM..OH..C22.2","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","SM (OH) C22:2","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 799.1633; MOLECULARFORMULA = C45H87N2O7P; KEGG = ; MOLECULE = SM (OH) C22:2; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = ; ISOMERIC = ; INCHI = ; MESH = Sphingomyelins; LMID = LMSP03010000","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","SM..OH..C24.1","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","SM (OH) C24:1","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 829.2327; MOLECULARFORMULA = C47H93N2O7P; KEGG = C00550; MOLECULE = Hydroxysphingomyelin with acyl residue sum C24:1; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = ; ISOMERIC = ; INCHI = ; MESH = Sphingomyelins; LMID = LMSP03010000","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","SM.C16.0","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","SM C16:0","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 703.02812; MOLECULARFORMULA = C39H79N2O6P; KEGG = C00550; MOLECULE = C16:0 Sphingomyelin; CAS = ; INCHIKEY = RWKUXQNLWDTSLO-GWQJGLRPSA-N; HMDB = HMDB10169           ; CHEBI = 17636               ; IUPAC = [(E,2S,3R)-2-(hexadecanoylamino)-3-hydroxyoctadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCC(=O)N[C@@H](COP(=O)([O-])OCC[N+](C)(C)C)[C@@H](/C=C/CCCCCCCCCCCCC)O; INCHI = InChI=1S/C39H79N2O6P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-38(42)37(36-47-48(44,45)46-35-34-41(3,4)5)40-39(43)33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h30,32,37-38,42H,6-29,31,33-36H2,1-5H3,(H-,40,43,44,45)/b32-30+/t37-,38+/m0/s1; MESH = Sphingomyelins; LMID = LMSP03010003","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","SM.C16.1","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","SM C16:1","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 701.0193; MOLECULARFORMULA = C39H77N2O6P; KEGG = ; MOLECULE = SM C16:1; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = ; ISOMERIC = ; INCHI = ; MESH = Sphingomyelins; LMID = LMSP03010000","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","SM.C18.0","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","SM C18:0","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 731.08128; MOLECULARFORMULA = C41H83N2O6P; KEGG = C00550; MOLECULE = C18:0 Sphingomyelin; CAS = 58909-84-5; INCHIKEY = LKQLRGMMMAHREN-YJFXYUILSA-N; HMDB = HMDB12099           ; CHEBI = 17636               ; IUPAC = [(E,2S,3R)-3-hydroxy-2-(octadecanoylamino)octadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCCCC(=O)N[C@@H](COP(=O)([O-])OCC[N+](C)(C)C)[C@@H](/C=C/CCCCCCCCCCCCC)O; INCHI = InChI=1S/C41H83N2O6P/c1-6-8-10-12-14-16-18-20-21-23-25-27-29-31-33-35-41(45)42-39(38-49-50(46,47)48-37-36-43(3,4)5)40(44)34-32-30-28-26-24-22-19-17-15-13-11-9-7-2/h32,34,39-40,44H,6-31,33,35-38H2,1-5H3,(H-,42,45,46,47)/b34-32+/t39-,40+/m0/s1; MESH = Sphingomyelins; LMID = LMSP03010001","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","SM.C18.1","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","SM C18:1","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 729.0654; MOLECULARFORMULA = C41H81N2O6P; KEGG = ; MOLECULE = C18:1;11Z-enoyl Sphingomyelin; CAS = ; INCHIKEY = -                          ; HMDB = HMDB12100           ; CHEBI = 17636               ; IUPAC = 2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(Z)-octadec-11-enoyl]amino]octadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium; ISOMERIC = CCCCCCCCCCCCCC=C[C@@H](O)[C@H](COP([O-])(=O)OCC[N+](C)(C)C)NC(=O)CCCCCCCCCC=C/CCCCCC; INCHI = InChI=1S/C41H81N2O6P/c1-6-8-10-12-14-16-18-20-21-23-25-27-29-31-33-35-41(45)42-39(38-49-50(46,47)48-37-36-43(3,4)5)40(44)34-32-30-28-26-24-22-19-17-15-13-11-9-7-2/h16,18,32,34,39-40,44H,6-15,17,19-31,33,35-38H2,1-5H3,(H-,42,45,46,47)/b18-16-,34-32+/t39-,40+/m0/s1; MESH = Sphingomyelins; LMID = ","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","SM.C20.2","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","SM C20:2","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 755.1107; MOLECULARFORMULA = C43H83N2O6P; KEGG = C00550; MOLECULE = Sphingomyelin with acyl residue sum C20:2; CAS = ; INCHIKEY = ; HMDB = ; CHEBI = ; IUPAC = ; ISOMERIC = ; INCHI = ; MESH = Sphingomyelins; LMID = LMSP03010000","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","SM.C24.0","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","SM C24:0","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 815.24076; MOLECULARFORMULA = C47H95N2O6P; KEGG = C00550; MOLECULE = C24:0 Sphingomyelin; CAS = ; INCHIKEY = QEDPUVGSSDPBMD-XTAIVQBESA-N; HMDB = HMDB11697           ; CHEBI = ; IUPAC = [(E,2S,3R)-3-hydroxy-2-(tetracosanoylamino)octadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](COP(=O)([O-])OCC[N+](C)(C)C)[C@@H](/C=C/CCCCCCCCCCCCC)O; INCHI = InChI=1S/C47H95N2O6P/c1-6-8-10-12-14-16-18-20-21-22-23-24-25-26-27-29-31-33-35-37-39-41-47(51)48-45(44-55-56(52,53)54-43-42-49(3,4)5)46(50)40-38-36-34-32-30-28-19-17-15-13-11-9-7-2/h38,40,45-46,50H,6-37,39,41-44H2,1-5H3,(H-,48,51,52,53)/b40-38+/t45-,46+/m0/s1; MESH = Sphingomyelins; LMID = LMSP03010008","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","SM.C24.1","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","SM C24:1","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 813.22488; MOLECULARFORMULA = C47H93N2O6P; KEGG = C00550; MOLECULE = C24:1 Sphingomyelin; CAS = ; INCHIKEY = WKZHECFHXLTOLJ-QYKFWSDSSA-N; HMDB = HMDB12107           ; CHEBI = 17636               ; IUPAC = [(E,2S,3R)-3-hydroxy-2-[[(Z)-tetracos-15-enoyl]amino]octadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)([O-])OCC[N+](C)(C)C)NC(=O)CCCCCCCCCCCCC/C=C\CCCCCCCC)O; INCHI = InChI=1S/C47H93N2O6P/c1-6-8-10-12-14-16-18-20-21-22-23-24-25-26-27-29-31-33-35-37-39-41-47(51)48-45(44-55-56(52,53)54-43-42-49(3,4)5)46(50)40-38-36-34-32-30-28-19-17-15-13-11-9-7-2/h20-21,38,40,45-46,50H,6-19,22-37,39,41-44H2,1-5H3,(H-,48,51,52,53)/b21-20-,40-38+/t45-,46+/m0/s1; MESH = Sphingomyelins; LMID = LMSP03010007","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","SM.C26.0","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","SM C26:0","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 843.29392; MOLECULARFORMULA = C49H99N2O6P; KEGG = C00550; MOLECULE = C26:0 Sphingomyelin; CAS = ; INCHIKEY = VRAWSAPVSSLIRI-MVUJCARGSA-N; HMDB = HMDB11698           ; CHEBI = 58216               ; IUPAC = [(E,2S,3R)-2-(hexacosanoylamino)-3-hydroxyoctadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](COP(=O)([O-])OCC[N+](C)(C)C)[C@@H](/C=C/CCCCCCCCCCCCC)O; INCHI = InChI=1S/C49H99N2O6P/c1-6-8-10-12-14-16-18-20-21-22-23-24-25-26-27-28-29-31-33-35-37-39-41-43-49(53)50-47(46-57-58(54,55)56-45-44-51(3,4)5)48(52)42-40-38-36-34-32-30-19-17-15-13-11-9-7-2/h40,42,47-48,52H,6-39,41,43-46H2,1-5H3,(H-,50,53,54,55)/b42-40+/t47-,48+/m0/s1; MESH = Sphingomyelins; LMID = LMSP03010010","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"
"","SM.C26.1","ADMCDUKEP180FIA","AD Metabolomics Consortium Duke Biocrates P180 Kit Flow injection analysis","-4","SM C26:1","-4","-4","-4","-4","","-4","-4","-4","-4","-4","DESCRIPTION = ; MOLECULEWEIGHT = 841.27804; MOLECULARFORMULA = C49H97N2O6P; KEGG = C00550; MOLECULE = C26:1,17Z-enoyl Sphingomyelin; CAS = ; INCHIKEY = YXEXWUZHFGYOHJ-UOJCCMJYSA-N; HMDB = ; CHEBI = ; IUPAC = [(E,2S,3R)-2-[[(Z)-hexacos-17-enoyl]amino]-3-hydroxyoctadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate; ISOMERIC = CCCCCCCCCCCCC/C=C/[C@H]([C@H](COP(=O)([O-])OCC[N+](C)(C)C)NC(=O)CCCCCCCCCCCCCCC/C=C\CCCCCCCC)O; INCHI = InChI=1S/C49H97N2O6P/c1-6-8-10-12-14-16-18-20-21-22-23-24-25-26-27-28-29-31-33-35-37-39-41-43-49(53)50-47(46-57-58(54,55)56-45-44-51(3,4)5)48(52)42-40-38-36-34-32-30-19-17-15-13-11-9-7-2/h20-21,40,42,47-48,52H,6-19,22-39,41,43-46H2,1-5H3,(H-,50,53,54,55)/b21-20-,42-40+/t47-,48+/m0/s1; MESH = Sphingomyelins; LMID = LMSP03010009","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","-4","2015-08-13 12:20:18.0"